{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:33:02Z","timestamp":1783110782340,"version":"3.54.6"},"reference-count":302,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00798-2","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:23:04Z","timestamp":1774855384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI-driven drug\u2013target interaction prediction: current progress, challenges, and future roadmap for precision medicine"],"prefix":"10.1007","volume":"40","author":[{"given":"Hiranmoy","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-152X","authenticated-orcid":false,"given":"Amlan","family":"Bishal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-8121","authenticated-orcid":false,"given":"Biplab","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakriti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahreen","family":"Taj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"798_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110249","volume":"192","author":"A Hassanali Aragh","year":"2025","unstructured":"Hassanali Aragh A, Moslemi Amirani R, Givehchian P et al (2025) MiRAGE-DTI: a novel approach for drug\u2013target interaction prediction by integrating drug and target similarity metrics. Comput Biol Med 192:110249. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110249","journal-title":"Comput Biol Med"},{"key":"798_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ipha.2025.01.001","volume":"3","author":"AJ Oyejide","year":"2025","unstructured":"Oyejide AJ, Adekunle YA, Abodunrin OD, Atoyebi EO (2025) Artificial intelligence, computational tools and robotics for drug discovery, development, and delivery. Intell Pharm 3:207\u2013224. https:\/\/doi.org\/10.1016\/j.ipha.2025.01.001","journal-title":"Intell Pharm"},{"key":"798_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.crbiot.2023.100164","volume":"7","author":"C Chakraborty","year":"2024","unstructured":"Chakraborty C, Bhattacharya M, Pal S, Lee S-S (2024) From machine learning to deep learning: advances of the recent data-driven paradigm shift in medicine and healthcare. Curr Res Biotechnol 7:100164. https:\/\/doi.org\/10.1016\/j.crbiot.2023.100164","journal-title":"Curr Res Biotechnol"},{"key":"798_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41573-025-01164-x","volume":"24","author":"Z Tanoli","year":"2025","unstructured":"Tanoli Z, Fern\u00e1ndez-Torras A, \u00d6zcan UO et al (2025) Computational drug repurposing: approaches, evaluation of in silico resources and case studies. Nat Rev Drug Discov 24:521\u2013542. https:\/\/doi.org\/10.1038\/s41573-025-01164-x","journal-title":"Nat Rev Drug Discov"},{"key":"798_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","volume":"616","author":"AV Sadybekov","year":"2023","unstructured":"Sadybekov AV, Katritch V (2023) Computational approaches streamlining drug discovery. Nature 616:673\u2013685. https:\/\/doi.org\/10.1038\/s41586-023-05905-z","journal-title":"Nature"},{"key":"798_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0324146","volume":"20","author":"H Shi","year":"2025","unstructured":"Shi H, Hu J, Zhang X et al (2025) Prediction of drug-target interactions based on substructure subsequences and cross-public attention mechanism. PLoS ONE 20:e0324146. https:\/\/doi.org\/10.1371\/journal.pone.0324146","journal-title":"PLoS ONE"},{"key":"798_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1021\/acs.jproteome.6b00618","volume":"16","author":"M Wen","year":"2017","unstructured":"Wen M, Zhang Z, Niu S et al (2017) Deep-learning-based drug\u2013target interaction prediction. J Proteome Res 16:1401\u20131409. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00618","journal-title":"J Proteome Res"},{"key":"798_CR8","doi-asserted-by":"publisher","DOI":"10.2174\/1570163820666230901160043","volume":"21","author":"AK Abdul Raheem","year":"2024","unstructured":"Abdul Raheem AK, Dhannoon BN (2024) Comprehensive review on drug-target interaction prediction: latest developments and overview. Curr Drug Discov Technol 21:e010923220652. https:\/\/doi.org\/10.2174\/1570163820666230901160043","journal-title":"Curr Drug Discov Technol"},{"key":"798_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1176400","author":"L Zhou","year":"2023","unstructured":"Zhou L, Wang Y, Peng L et al (2023) Identifying potential drug-target interactions based on ensemble deep learning. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2023.1176400","journal-title":"Front Aging Neurosci"},{"key":"798_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.fmre.2024.04.021","volume":"5","author":"AU Rehman","year":"2025","unstructured":"Rehman AU, Li M, Wu B et al (2025) Role of artificial intelligence in revolutionizing drug discovery. Fundam Res 5:1273\u20131287. https:\/\/doi.org\/10.1016\/j.fmre.2024.04.021","journal-title":"Fundam Res"},{"key":"798_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/1389203718666161108091609","volume":"19","author":"S Anusuya","year":"2018","unstructured":"Anusuya S, Kesherwani M, Priya KV et al (2018) Drug-target interactions: prediction methods and applications. CPPS 19:537\u2013561. https:\/\/doi.org\/10.2174\/1389203718666161108091609","journal-title":"CPPS"},{"key":"798_CR12","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.2147\/dddt.s257494","volume":"14","author":"XH Makhoba","year":"2020","unstructured":"Makhoba XH, Viegas C Jr, Mosa RA et al (2020) <p>Potential impact of the multi-target drug approach in the treatment of some complex diseases<\/p>. DDDT 14:3235\u20133249. https:\/\/doi.org\/10.2147\/dddt.s257494","journal-title":"DDDT"},{"key":"798_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100737","volume":"23","author":"J Su","year":"2024","unstructured":"Su J, Yang L, Sun Z, Zhan X (2024) Personalized drug therapy: innovative concept guided with Proteoformics. Mol Cell Proteomics 23:100737. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100737","journal-title":"Mol Cell Proteomics"},{"key":"798_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/bib\/bby002","volume":"20","author":"A Ezzat","year":"2019","unstructured":"Ezzat A, Wu M, Li X-L, Kwoh C-K (2019) Computational prediction of drug\u2013target interactions using chemogenomic approaches: an empirical survey. Br Bioinf 20:1337\u20131357. https:\/\/doi.org\/10.1093\/bib\/bby002","journal-title":"Br Bioinf"},{"key":"798_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf625","volume":"26","author":"S Savander","year":"2025","unstructured":"Savander S, Curabaz NN, Abbasi AM et al (2025) Data-driven strategies for drug repurposing: insights, recommendations, and case studies. Br Bioinf 26:bbaf625. https:\/\/doi.org\/10.1093\/bib\/bbaf625","journal-title":"Br Bioinf"},{"key":"798_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.54254\/2753-8818\/15\/20240387","volume":"15","author":"M Wang","year":"2023","unstructured":"Wang M (2023) High-throughput screening technologies for drug discovery. TNS 15:18\u201323. https:\/\/doi.org\/10.54254\/2753-8818\/15\/20240387","journal-title":"TNS"},{"key":"798_CR17","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/s41598-023-30026-y","volume":"13","author":"H Abbasi Mesrabadi","year":"2023","unstructured":"Abbasi Mesrabadi H, Faez K, Pirgazi J (2023) Drug\u2013target interaction prediction based on protein features, using wrapper feature selection. Sci Rep 13:3594. https:\/\/doi.org\/10.1038\/s41598-023-30026-y","journal-title":"Sci Rep"},{"key":"798_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03932-6","volume":"15","author":"MA Talukder","year":"2025","unstructured":"Talukder MA, Kazi M, Alazab A (2025) Predicting drug-target interactions using machine learning with improved data balancing and feature engineering. Sci Rep 15:19495. https:\/\/doi.org\/10.1038\/s41598-025-03932-6","journal-title":"Sci Rep"},{"key":"798_CR19","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1109\/jbhi.2024.3354953","volume":"29","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, Xu D, Ding D, Ding Y (2025) Prediction of drug-target interactions with high-quality negative samples and a network-based deep learning framework. IEEE J Biomed Health Inform 29:1567\u20131578. https:\/\/doi.org\/10.1109\/jbhi.2024.3354953","journal-title":"IEEE J Biomed Health Inform"},{"key":"798_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-023-00689-w","author":"H Atas Guvenilir","year":"2023","unstructured":"Atas Guvenilir H, Do\u011fan T (2023) How to approach machine learning-based prediction of drug\/compound\u2013target interactions. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-023-00689-w","journal-title":"J Cheminform"},{"key":"798_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ipha.2024.02.009","volume":"2","author":"S Yadav","year":"2024","unstructured":"Yadav S, Singh A, Singhal R, Yadav JP (2024) Revolutionizing drug discovery: the impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry. Intell Pharm 2:367\u2013380. https:\/\/doi.org\/10.1016\/j.ipha.2024.02.009","journal-title":"Intell Pharm"},{"key":"798_CR22","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/j.apsb.2024.03.002","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Gui Y, Rao J et al (2024) In silico off-target profiling for enhanced drug safety assessment. Acta Pharm Sin B 14:2927\u20132941. https:\/\/doi.org\/10.1016\/j.apsb.2024.03.002","journal-title":"Acta Pharm Sin B"},{"key":"798_CR23","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/bib\/bbz103","volume":"21","author":"FE Agamah","year":"2020","unstructured":"Agamah FE, Mazandu GK, Hassan R et al (2020) Computational\/in silico methods in drug target and lead prediction. Br Bioinf 21:1663\u20131675. https:\/\/doi.org\/10.1093\/bib\/bbz103","journal-title":"Br Bioinf"},{"key":"798_CR24","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1038\/s41591-024-03233-x","volume":"30","author":"K Huang","year":"2024","unstructured":"Huang K, Chandak P, Wang Q et al (2024) A foundation model for clinician-centered drug repurposing. Nat Med 30:3601\u20133613. https:\/\/doi.org\/10.1038\/s41591-024-03233-x","journal-title":"Nat Med"},{"key":"798_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.imj.2024.100095","volume":"3","author":"C Lv","year":"2024","unstructured":"Lv C, Guo W, Yin X et al (2024) Innovative applications of artificial intelligence during the COVID-19 pandemic. Infect Med 3:100095. https:\/\/doi.org\/10.1016\/j.imj.2024.100095","journal-title":"Infect Med"},{"key":"798_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1124\/pharmrev.123.001028","volume":"76","author":"Z-C Jia","year":"2024","unstructured":"Jia Z-C, Yang X, Wu Y-K et al (2024) The art of finding the right drug target: emerging methods and strategies. Pharmacol Rev 76:896\u2013914. https:\/\/doi.org\/10.1124\/pharmrev.123.001028","journal-title":"Pharmacol Rev"},{"key":"798_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020144","volume":"17","author":"X Du","year":"2016","unstructured":"Du X, Li Y, Xia Y-L et al (2016) Insights into protein\u2013ligand interactions: mechanisms, models, and methods. Int J Mol Sci 17:144. https:\/\/doi.org\/10.3390\/ijms17020144","journal-title":"Int J Mol Sci"},{"key":"798_CR28","unstructured":"Abosamak NR, Shahin MH (2025) Beta2 Receptor Agonists and Antagonists. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"798_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drudis.2021.09.008","volume":"27","author":"JS Schardt","year":"2022","unstructured":"Schardt JS, Jhajj HS, Meara RL et al (2022) Agonist antibody discovery: experimental, computational, and rational engineering approaches. Drug Discov Today 27:31\u201348. https:\/\/doi.org\/10.1016\/j.drudis.2021.09.008","journal-title":"Drug Discov Today"},{"key":"798_CR30","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3390\/cells9091923","volume":"9","author":"MC Michel","year":"2020","unstructured":"Michel MC, Michel-Reher MB, Hein P (2020) A systematic review of inverse agonism at adrenoceptor subtypes. Cells 9:1923. https:\/\/doi.org\/10.3390\/cells9091923","journal-title":"Cells"},{"key":"798_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179181","volume":"22","author":"M De La Fuente","year":"2021","unstructured":"De La Fuente M, Lombardero L, G\u00f3mez-Gonz\u00e1lez A et al (2021) Enzyme therapy: current challenges and future perspectives. Int J Mol Sci 22:9181. https:\/\/doi.org\/10.3390\/ijms22179181","journal-title":"Int J Mol Sci"},{"key":"798_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02036-3","author":"H Nada","year":"2024","unstructured":"Nada H, Choi Y, Kim S et al (2024) New insights into protein\u2013protein interaction modulators in drug discovery and therapeutic advance. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-02036-3","journal-title":"Sig Transduct Target Ther"},{"key":"798_CR33","unstructured":"Rehman S, Rahimi N, Dimri M (2025) Biochemistry, G Protein Coupled Receptors. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"798_CR34","unstructured":"Overview of protease and phosphatase inhibition for protein preparation - IN. https:\/\/www.thermofisher.com\/in\/en\/home\/life-science\/protein-biology\/protein-biology-learning-center\/protein-biology-resource-library\/pierce-protein-methods\/protease-phosphatase-inhibitors.html. Accessed 9 July 2025"},{"key":"798_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01888-z","author":"J Su","year":"2024","unstructured":"Su J, Song Y, Zhu Z et al (2024) Cell\u2013cell communication: new insights and clinical implications. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-01888-z","journal-title":"Sig Transduct Target Ther"},{"key":"798_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225650","volume":"13","author":"L Wordeman","year":"2021","unstructured":"Wordeman L, Vicente JJ (2021) Microtubule targeting agents in disease: classic drugs, novel roles. Cancers 13:5650. https:\/\/doi.org\/10.3390\/cancers13225650","journal-title":"Cancers"},{"key":"798_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1568009619666191007112516","volume":"20","author":"M Godzieba","year":"2020","unstructured":"Godzieba M, Ciesielski S (2020) Natural DNA intercalators as promising therapeutics for cancer and infectious diseases. Curr Cancer Drug Targets 20:19\u201332. https:\/\/doi.org\/10.2174\/1568009619666191007112516","journal-title":"Curr Cancer Drug Targets"},{"key":"798_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104429","volume":"88","author":"WYV Lau","year":"2023","unstructured":"Lau WYV, Taylor PK, Brinkman FSL, Lee AHY (2023) Pathogen-associated gene discovery workflows for novel antivirulence therapeutic development. EBioMedicine 88:104429. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104429","journal-title":"EBioMedicine"},{"key":"798_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1375522","author":"X Zeng","year":"2024","unstructured":"Zeng X, Li S-J, Lv S-Q et al (2024) A comprehensive review of the recent advances on predicting drug-target affinity based on deep learning. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1375522","journal-title":"Front Pharmacol"},{"key":"798_CR40","unstructured":"Rai S, Pandey P, Gupta A, Sharma S (2023) Virtual screening and high-throughput screening in drug discovery"},{"key":"798_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01427-2","author":"T-S Wong","year":"2023","unstructured":"Wong T-S, Li G, Li S et al (2023) G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01427-2","journal-title":"Sig Transduct Target Ther"},{"key":"798_CR42","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1038\/s41598-018-33120-8","volume":"9","author":"M Rinne","year":"2019","unstructured":"Rinne M, Tanoli Z-U-R, Khan A, Xhaard H (2019) Cartography of rhodopsin-like G protein-coupled receptors across vertebrate genomes. Sci Rep 9:7058. https:\/\/doi.org\/10.1038\/s41598-018-33120-8","journal-title":"Sci Rep"},{"key":"798_CR43","unstructured":"Sam C, Bordoni B (2025) Physiology, acetylcholine. In: StatPearls. StatPearls Publishing, Treasure Island"},{"key":"798_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/life15060888","volume":"15","author":"R Felix","year":"2025","unstructured":"Felix R, Corzo-Lopez A, Sandoval A (2025) Voltage-gated ion channels in neuropathic pain signaling. Life 15:888. https:\/\/doi.org\/10.3390\/life15060888","journal-title":"Life"},{"key":"798_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-016-0009-6","author":"A Bhardwaj","year":"2017","unstructured":"Bhardwaj A, Kaur J, Wuest M, Wuest F (2017) In situ click chemistry generation of cyclooxygenase-2 inhibitors. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-016-0009-6","journal-title":"Nat Commun"},{"key":"798_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1573408019666230731113105","volume":"19","author":"K Singh","year":"2023","unstructured":"Singh K, Gupta JK, Pathak D, Kumar S (2023) The use of enzyme inhibitors in drug discovery: current strategies andfuture prospects. Clin Exp Immunol 19:157\u2013166. https:\/\/doi.org\/10.2174\/1573408019666230731113105","journal-title":"Clin Exp Immunol"},{"key":"798_CR47","unstructured":"Lee S (2025) The role of intracellular receptors. https:\/\/www.numberanalytics.com\/blog\/role-intracellular-receptors-pharmacology-toxicology-drug-development. Accessed 10 July 2025"},{"key":"798_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-0716-1554-6_8","volume-title":"Enzyme kinetics in drug metabolism","author":"AG Roberts","year":"2021","unstructured":"Roberts AG (2021) The Structure and mechanism of drug transporters. In: Nagar S, Argikar UA, Tweedie D (eds) Enzyme kinetics in drug metabolism. Springer, New York, pp 193\u2013234"},{"key":"798_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.175","author":"K Pang","year":"2022","unstructured":"Pang K, Wang W, Qin J et al (2022) Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. MedComm. https:\/\/doi.org\/10.1002\/mco2.175","journal-title":"MedComm"},{"key":"798_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101223","volume":"81","author":"GL Beretta","year":"2025","unstructured":"Beretta GL, Cassinelli G, Rossi G et al (2025) Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies. Drug Resist Updat 81:101223. https:\/\/doi.org\/10.1016\/j.drup.2025.101223","journal-title":"Drug Resist Updat"},{"key":"798_CR51","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1124\/pr.120.019554","volume":"72","author":"A-M Yu","year":"2020","unstructured":"Yu A-M, Choi YH, Tu M-J (2020) RNA drugs and RNA targets for small molecules: principles, progress, and challenges. Pharmacol Rev 72:862\u2013898. https:\/\/doi.org\/10.1124\/pr.120.019554","journal-title":"Pharmacol Rev"},{"key":"798_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcsw.2024.100135","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y, Song M, Chang W (2024) Antimicrobial peptides and proteins against drug-resistant pathogens. Cell Surf 12:100135. https:\/\/doi.org\/10.1016\/j.tcsw.2024.100135","journal-title":"Cell Surf"},{"key":"798_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-030-95895-4_3","volume-title":"Drug target selection and validation","author":"A Rasul","year":"2022","unstructured":"Rasul A, Riaz A, Sarfraz I et al (2022) Target identification approaches in drug discovery. In: Scotti MT, Bellera CL (eds) Drug target selection and validation. Springer International Publishing, Cham, pp 41\u201359"},{"key":"798_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-017-0181-2","author":"RR Ramsay","year":"2018","unstructured":"Ramsay RR, Popovic\u2010Nikolic MR, Nikolic K et al (2018) A perspective on multi\u2010target drug discovery and design for complex diseases. Clin Transl Med. https:\/\/doi.org\/10.1186\/s40169-017-0181-2","journal-title":"Clin Transl Med"},{"key":"798_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG et al (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Sig Transduct Target Ther"},{"key":"798_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01705-z","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01705-z","journal-title":"Sig Transduct Target Ther"},{"key":"798_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155161","volume":"254","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani M, Nsairat H, Matalka II et al (2024) The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia. Pathol Res Pract 254:155161. https:\/\/doi.org\/10.1016\/j.prp.2024.155161","journal-title":"Pathol Res Pract"},{"key":"798_CR58","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2147\/ott.s404648","volume":"16","author":"M Abdellateif","year":"2023","unstructured":"Abdellateif M, Bayoumi A, Mohammed M (2023) c-Kit receptors as a therapeutic target in cancer: current insights. OTT 16:785\u2013799. https:\/\/doi.org\/10.2147\/ott.s404648","journal-title":"OTT"},{"key":"798_CR59","doi-asserted-by":"publisher","DOI":"10.1177\/03946320251316731","author":"M Fakhkhari","year":"2025","unstructured":"Fakhkhari M, Salih I, Errafii K et al (2025) Meta-analysis of EGFR gene polymorphisms and lung cancer risk. Int J Immunopathol Pharmacol. https:\/\/doi.org\/10.1177\/03946320251316731","journal-title":"Int J Immunopathol Pharmacol"},{"key":"798_CR60","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/j.cllc.2025.03.004","volume":"26","author":"JP Casta\u00f1eda-Gonz\u00e1lez","year":"2025","unstructured":"Casta\u00f1eda-Gonz\u00e1lez JP, Parra-Medina R, Riess JW et al (2025) Genetic ancestry and lung cancer in Latin American patients: a crucial step for understanding a diverse population. Clin Lung Cancer 26:e342\u2013e352. https:\/\/doi.org\/10.1016\/j.cllc.2025.03.004","journal-title":"Clin Lung Cancer"},{"key":"798_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2024.102975","volume":"90","author":"MP Bemelmans","year":"2025","unstructured":"Bemelmans MP, Cournia Z, Damm-Ganamet KL et al (2025) Computational advances in discovering cryptic pockets for drug discovery. Curr Opin Struct Biol 90:102975. https:\/\/doi.org\/10.1016\/j.sbi.2024.102975","journal-title":"Curr Opin Struct Biol"},{"key":"798_CR62","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11684-018-0650-z","volume":"12","author":"PA Carroll","year":"2018","unstructured":"Carroll PA, Freie BW, Mathsyaraja H, Eisenman RN (2018) The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis. Front Med 12:412\u2013425. https:\/\/doi.org\/10.1007\/s11684-018-0650-z","journal-title":"Front Med"},{"key":"798_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1425456","author":"E Hern\u00e1ndez-Lemus","year":"2024","unstructured":"Hern\u00e1ndez-Lemus E, Ochoa S (2024) Methods for multi-omic data integration in cancer research. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2024.1425456","journal-title":"Front Genet"},{"key":"798_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01641-y","author":"M Soltani","year":"2025","unstructured":"Soltani M, Abbaszadeh M, Fouladseresht H et al (2025) PD-L1 importance in malignancies comprehensive insights into the role of PD-L1 in malignancies: from molecular mechanisms to therapeutic opportunities. Clin Exp Med. https:\/\/doi.org\/10.1007\/s10238-025-01641-y","journal-title":"Clin Exp Med"},{"key":"798_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040398","volume":"14","author":"L Cheslow","year":"2024","unstructured":"Cheslow L, Snook AE, Waldman SA (2024) Biomarkers for managing neurodegenerative diseases. Biomolecules 14:398. https:\/\/doi.org\/10.3390\/biom14040398","journal-title":"Biomolecules"},{"key":"798_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","volume":"44","author":"FW Pun","year":"2023","unstructured":"Pun FW, Ozerov IV, Zhavoronkov A (2023) AI-powered therapeutic target discovery. Trends Pharmacol Sci 44:561\u2013572. https:\/\/doi.org\/10.1016\/j.tips.2023.06.010","journal-title":"Trends Pharmacol Sci"},{"key":"798_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s44395-025-00007-3","author":"S Kant","year":"2025","unstructured":"Kant S, Deepika RS (2025) Artificial intelligence in drug discovery and development: transforming challenges into opportunities. Discov Pharm Sci. https:\/\/doi.org\/10.1007\/s44395-025-00007-3","journal-title":"Discov Pharm Sci"},{"key":"798_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100039","volume":"2","author":"S Singh","year":"2024","unstructured":"Singh S, Gupta H, Sharma P, Sahi S (2024) Advances in Artificial Intelligence (AI)-assisted approaches in drug screening. Artif Intell Chem 2:100039. https:\/\/doi.org\/10.1016\/j.aichem.2023.100039","journal-title":"Artif Intell Chem"},{"key":"798_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1504","author":"S Yang","year":"2021","unstructured":"Yang S, Ye Q, Ding J et al (2021) Current advances in ligand-based target prediction. WIREs Comput Mol Sci. https:\/\/doi.org\/10.1002\/wcms.1504","journal-title":"WIREs Comput Mol Sci"},{"key":"798_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2024.100077","volume":"2","author":"K L\u00f3pez-P\u00e9rez","year":"2024","unstructured":"L\u00f3pez-P\u00e9rez K, Avellaneda-Tamayo JF, Chen L et al (2024) Molecular similarity: theory, applications, and perspectives. Artif Intell Chem 2:100077. https:\/\/doi.org\/10.1016\/j.aichem.2024.100077","journal-title":"Artif Intell Chem"},{"key":"798_CR71","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1021\/acs.jcim.0c00993","volume":"61","author":"H Safizadeh","year":"2021","unstructured":"Safizadeh H, Simpkins SW, Nelson J et al (2021) Improving measures of chemical structural similarity using machine learning on chemical-genetic interactions. J Chem Inf Model 61:4156\u20134172. https:\/\/doi.org\/10.1021\/acs.jcim.0c00993","journal-title":"J Chem Inf Model"},{"key":"798_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-024-00830-3","author":"D Boldini","year":"2024","unstructured":"Boldini D, Ballabio D, Consonni V et al (2024) Effectiveness of molecular fingerprints for exploring the chemical space of natural products. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-024-00830-3","journal-title":"J Cheminform"},{"key":"798_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.606668","author":"L Xie","year":"2020","unstructured":"Xie L, Xu L, Kong R et al (2020) Improvement of prediction performance with conjoint molecular fingerprint in deep learning. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.606668","journal-title":"Front Pharmacol"},{"key":"798_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1544","author":"A Varela-Rial","year":"2022","unstructured":"Varela-Rial A, Majewski M, De Fabritiis G (2022) Structure based virtual screening: Fast and slow. WIREs Comput Mol Sci. https:\/\/doi.org\/10.1002\/wcms.1544","journal-title":"WIREs Comput Mol Sci"},{"key":"798_CR75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN et al (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25:197\u2013206. https:\/\/doi.org\/10.1038\/nbt1284","journal-title":"Nat Biotechnol"},{"key":"798_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemolab.2024.105278","volume":"256","author":"J Li","year":"2025","unstructured":"Li J, Zhao T, Yang Q et al (2025) A review of quantitative structure-activity relationship: the development and current status of data sets, molecular descriptors and mathematical models. Chemom Intell Lab Syst 256:105278. https:\/\/doi.org\/10.1016\/j.chemolab.2024.105278","journal-title":"Chemom Intell Lab Syst"},{"key":"798_CR77","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.csbj.2024.07.003","volume":"23","author":"AI Odugbemi","year":"2024","unstructured":"Odugbemi AI, Nyirenda C, Christoffels A, Egieyeh SA (2024) Artificial intelligence in antidiabetic drug discovery: the advances in QSAR and the prediction of \u03b1-glucosidase inhibitors. Comput Struct Biotechnol J 23:2964\u20132977. https:\/\/doi.org\/10.1016\/j.csbj.2024.07.003","journal-title":"Comput Struct Biotechnol J"},{"key":"798_CR78","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2483631","author":"R Shahin","year":"2025","unstructured":"Shahin R, Jaafreh S, Azzam Y (2025) Tracking protein kinase targeting advances: integrating QSAR into machine learning for kinase-targeted drug discovery. Future Sci OA. https:\/\/doi.org\/10.1080\/20565623.2025.2483631","journal-title":"Future Sci OA"},{"key":"798_CR79","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/app15031206","volume":"15","author":"B Vasilev","year":"2025","unstructured":"Vasilev B, Atanasova M (2025) A (comprehensive) review of the application of quantitative structure-activity relationship (QSAR) in the prediction of new compounds with anti-breast cancer activity. Appl Sci 15:1206. https:\/\/doi.org\/10.3390\/app15031206","journal-title":"Appl Sci"},{"key":"798_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202000113","author":"VM Alves","year":"2021","unstructured":"Alves VM, Bobrowski T, Melo\u2010Filho CC et al (2021) QSAR modeling of SARS\u2010CoV Mpro inhibitors identifies Sufugolix, Cenicriviroc, Proglumetacin, and other drugs as candidates for repurposing against SARS\u2010CoV\u20102. Mol Inform. https:\/\/doi.org\/10.1002\/minf.202000113","journal-title":"Mol Inform"},{"key":"798_CR81","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","volume":"26","author":"D Paul","year":"2021","unstructured":"Paul D, Sanap G, Shenoy S et al (2021) Artificial intelligence in drug discovery and development. Drug Discov Today 26:80\u201393. https:\/\/doi.org\/10.1016\/j.drudis.2020.10.010","journal-title":"Drug Discov Today"},{"key":"798_CR82","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/ph15050646","volume":"15","author":"D Giordano","year":"2022","unstructured":"Giordano D, Biancaniello C, Argenio MA, Facchiano A (2022) Drug design by pharmacophore and virtual screening approach. Pharmaceuticals (Basel) 15:646. https:\/\/doi.org\/10.3390\/ph15050646","journal-title":"Pharmaceuticals (Basel)"},{"key":"798_CR83","doi-asserted-by":"crossref","unstructured":"Giordano D, Biancaniello C, Argenio MA, Facchiano A (2022) Computational approaches in drug designing. In: Bioinformatics. Elsevier, pp 207\u2013217","DOI":"10.1016\/B978-0-323-89775-4.00010-9"},{"key":"798_CR84","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/ddc2020017","volume":"2","author":"T Oliveira","year":"2023","unstructured":"Oliveira T, Silva M, Maia E et al (2023) Virtual screening algorithms in drug discovery: a review focused on machine and deep learning methods. DDC 2:311\u2013334. https:\/\/doi.org\/10.3390\/ddc2020017","journal-title":"DDC"},{"key":"798_CR85","doi-asserted-by":"crossref","unstructured":"Evans EM, Taofeek OO, Gwira TM, et al (2025) Discovery of novel trypanothione reductase inhibitors through pharmacophore modeling, virtual screening and molecular dynamics simulations. New insights for human African trypanosomiasis","DOI":"10.1101\/2025.04.18.649577"},{"key":"798_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202500492","author":"VS Suryawanshi","year":"2025","unstructured":"Suryawanshi VS, Islam ML, Eldesoky GE et al (2025) Identification of acetylcholinesterase inhibitors through a pharmacophore-guided deep learning approach for therapeutic applications in Alzheimer\u2019s disease. ChemistrySelect. https:\/\/doi.org\/10.1002\/slct.202500492","journal-title":"ChemistrySelect"},{"key":"798_CR87","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae693","author":"Z Luo","year":"2024","unstructured":"Luo Z, Wu W, Sun Q, Wang J (2024) Accurate and transferable drug\u2013target interaction prediction with DrugLAMP. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/btae693","journal-title":"Bioinformatics"},{"key":"798_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01589-z","author":"X Xie","year":"2023","unstructured":"Xie X, Yu T, Li X et al (2023) Recent advances in targeting the \u201cundruggable\u201d proteins: from drug discovery to clinical trials. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01589-z","journal-title":"Sig Transduct Target Ther"},{"key":"798_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04474-z","author":"Y Cao","year":"2023","unstructured":"Cao Y, Yang Y, Hu Q, Wei G (2023) Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-023-04474-z","journal-title":"J Transl Med"},{"key":"798_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab476","author":"A Dhakal","year":"2022","unstructured":"Dhakal A, McKay C, Tanner JJ, Cheng J (2022) Artificial intelligence in the prediction of protein\u2013ligand interactions: recent advances and future directions. Brief Bioinf. https:\/\/doi.org\/10.1093\/bib\/bbab476","journal-title":"Brief Bioinf"},{"key":"798_CR91","doi-asserted-by":"publisher","first-page":"13692","DOI":"10.1021\/acs.jmedchem.2c00708","volume":"65","author":"TR Stachowski","year":"2022","unstructured":"Stachowski TR, Fischer M (2022) Large-scale ligand perturbations of the protein conformational landscape reveal state-specific interaction hotspots. J Med Chem 65:13692\u201313704. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00708","journal-title":"J Med Chem"},{"key":"798_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010049","volume":"15","author":"Y Chang","year":"2022","unstructured":"Chang Y, Hawkins BA, Du JJ et al (2022) A guide to in silico drug design. Pharmaceutics 15:49. https:\/\/doi.org\/10.3390\/pharmaceutics15010049","journal-title":"Pharmaceutics"},{"key":"798_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-021-00242-1","author":"J-Y An","year":"2021","unstructured":"An J-Y, Meng F-R, Yan Z-J (2021) An efficient computational method for predicting drug-target interactions using weighted extreme learning machine and speed up robot features. BioData Min. https:\/\/doi.org\/10.1186\/s13040-021-00242-1","journal-title":"BioData Min"},{"key":"798_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ph17010022","volume":"17","author":"SK Niazi","year":"2023","unstructured":"Niazi SK, Mariam Z (2023) Computer-aided drug design and drug discovery: a prospective analysis. Pharmaceuticals 17:22. https:\/\/doi.org\/10.3390\/ph17010022","journal-title":"Pharmaceuticals"},{"key":"798_CR95","unstructured":"(2022) Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2. In: Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 Infection. Elsevier, pp 207\u2013246"},{"key":"798_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40160-2","author":"PC Agu","year":"2023","unstructured":"Agu PC, Afiukwa CA, Orji OU et al (2023) Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-40160-2","journal-title":"Sci Rep"},{"key":"798_CR97","doi-asserted-by":"crossref","unstructured":"Khanna V, Ranganathan S, Petrovsky N (2019) Rational structure-based drug design. In: Encyclopedia of bioinformatics and computational biology. Elsevier, pp 585\u2013600","DOI":"10.1016\/B978-0-12-809633-8.20275-6"},{"key":"798_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27207103","volume":"27","author":"J Liao","year":"2022","unstructured":"Liao J, Wang Q, Wu F, Huang Z (2022) In silico methods for identification of potential active sites of therapeutic targets. Molecules 27:7103. https:\/\/doi.org\/10.3390\/molecules27207103","journal-title":"Molecules"},{"key":"798_CR99","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12539-019-00327-w","volume":"11","author":"J Li","year":"2019","unstructured":"Li J, Fu A, Zhang L (2019) An overview of scoring functions used for protein-ligand interactions in molecular docking. Interdiscip Sci Comput Life Sci 11:320\u2013328. https:\/\/doi.org\/10.1007\/s12539-019-00327-w","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"798_CR100","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.3390\/ijms20184574","volume":"20","author":"PHM Torres","year":"2019","unstructured":"Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP (2019) Key topics in molecular docking for drug design. Int J Mol Sci 20:4574. https:\/\/doi.org\/10.3390\/ijms20184574","journal-title":"Int J Mol Sci"},{"key":"798_CR101","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi L, Rastelli G (2019) Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci 20:4331. https:\/\/doi.org\/10.3390\/ijms20184331","journal-title":"Int J Mol Sci"},{"key":"798_CR102","unstructured":"(2023) Molecular docking in the study of ligand-protein recognition: an overview. In: biomedical engineering. IntechOpen"},{"key":"798_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091107","volume":"17","author":"MAA Noor","year":"2024","unstructured":"Noor MAA, Haq MM, Chowdhury MAR et al (2024) In silico exploration of novel EGFR kinase mutant-selective inhibitors using a hybrid computational approach. Pharmaceuticals 17:1107. https:\/\/doi.org\/10.3390\/ph17091107","journal-title":"Pharmaceuticals"},{"key":"798_CR104","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1021\/acs.jctc.1c00136","volume":"17","author":"EB Miller","year":"2021","unstructured":"Miller EB, Murphy RB, Sindhikara D et al (2021) Reliable and accurate solution to the induced fit docking problem for protein\u2013ligand binding. J Chem Theory Comput 17:2630\u20132639. https:\/\/doi.org\/10.1021\/acs.jctc.1c00136","journal-title":"J Chem Theory Comput"},{"key":"798_CR105","unstructured":"(2022) Unraveling of inhibitory potential of phytochemicals against SARS-CoV-2 using in-silico approach. In: Herbal medicines. Elsevier, pp 471\u2013500"},{"key":"798_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1298245","author":"T Jin","year":"2023","unstructured":"Jin T, Xu W, Chen R et al (2023) Discovery of potential WEE1 inhibitors via hybrid virtual screening. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1298245","journal-title":"Front Pharmacol"},{"key":"798_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040524","volume":"15","author":"C Agoni","year":"2025","unstructured":"Agoni C, Fern\u00e1ndez-D\u00edaz R, Timmons PB et al (2025) Molecular modelling in bioactive peptide discovery and characterisation. Biomolecules 15:524. https:\/\/doi.org\/10.3390\/biom15040524","journal-title":"Biomolecules"},{"key":"798_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01089","author":"IA Guedes","year":"2018","unstructured":"Guedes IA, Pereira FSS, Dardenne LE (2018) Empirical scoring functions for structure-based virtual screening: applications, critical aspects, and challenges. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.01089","journal-title":"Front Pharmacol"},{"key":"798_CR109","unstructured":"BioSolveIT_company_overview_2025.pdf"},{"key":"798_CR110","unstructured":"Overview of DOCK. https:\/\/dock.compbio.ucsf.edu\/Overview_of_DOCK\/index.htm. Accessed 11 July 2025"},{"key":"798_CR111","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier A, Zoete V, Michielin O (2011) SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 39:W270\u2013W277. https:\/\/doi.org\/10.1093\/nar\/gkr366","journal-title":"Nucleic Acids Res"},{"key":"798_CR112","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"DR Koes","year":"2013","unstructured":"Koes DR, Baumgartner MP, Camacho CJ (2013) Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model 53:1893\u20131904. https:\/\/doi.org\/10.1021\/ci300604z","journal-title":"J Chem Inf Model"},{"key":"798_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-021-00522-2","volume":"13","author":"AT McNutt","year":"2021","unstructured":"McNutt AT, Francoeur P, Aggarwal R et al (2021) GNINA 1.0: molecular docking with deep learning. J Cheminform 13:43. https:\/\/doi.org\/10.1186\/s13321-021-00522-2","journal-title":"J Cheminform"},{"key":"798_CR114","unstructured":"MIT-IBM Watson AI Lab, Report to the President 2022\u20132023"},{"key":"798_CR115","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1021\/acs.jcim.4c01014","volume":"65","author":"S Xia","year":"2025","unstructured":"Xia S, Gu Y, Zhang Y (2025) Normalized protein-ligand distance likelihood score for end-to-end blind docking and virtual screening. J Chem Inf Model 65:1101\u20131114. https:\/\/doi.org\/10.1021\/acs.jcim.4c01014","journal-title":"J Chem Inf Model"},{"key":"798_CR116","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5582\/ddt.2023.01063","volume":"17","author":"Y Li","year":"2023","unstructured":"Li Y, Li L, Wang S, Tang X (2023) EQUIBIND: a geometric deep learning-based protein-ligand binding prediction method. DD&T 17:363\u2013364. https:\/\/doi.org\/10.5582\/ddt.2023.01063","journal-title":"DD&T"},{"key":"798_CR117","doi-asserted-by":"publisher","DOI":"10.21577\/0103-5053.20240112","author":"A Lima","year":"2024","unstructured":"Lima A, Penteado A, De Jesus J et al (2024) Structure-based virtual screening: successes and pitfalls. J Braz Chem Soc. https:\/\/doi.org\/10.21577\/0103-5053.20240112","journal-title":"J Braz Chem Soc"},{"key":"798_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204723","volume":"25","author":"J V\u00e1zquez","year":"2020","unstructured":"V\u00e1zquez J, L\u00f3pez M, Gibert E et al (2020) Merging ligand-based and structure-based methods in drug discovery: an overview of combined virtual screening approaches. Molecules 25:4723. https:\/\/doi.org\/10.3390\/molecules25204723","journal-title":"Molecules"},{"key":"798_CR119","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1021\/acs.jctc.5c00046","volume":"21","author":"A Croitoru","year":"2025","unstructured":"Croitoru A, Kumar A, Lambry J-C et al (2025) Increasing the accuracy and robustness of the CHARMM general force field with an expanded training set. J Chem Theory Comput 21:3044\u20133065. https:\/\/doi.org\/10.1021\/acs.jctc.5c00046","journal-title":"J Chem Theory Comput"},{"key":"798_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2024.102023","volume":"32","author":"YTM Alharbi","year":"2024","unstructured":"Alharbi YTM, Abdel-Mageed WM, Basudan OA et al (2024) Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: in vitro, molecular docking and simulation analysis. Saudi Pharm J 32:102023. https:\/\/doi.org\/10.1016\/j.jsps.2024.102023","journal-title":"Saudi Pharm J"},{"key":"798_CR121","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10989-020-10115-6","volume":"27","author":"V Balakrishnan","year":"2021","unstructured":"Balakrishnan V, Lakshminarayanan K (2021) Screening of FDA approved drugs against SARS-CoV-2 main protease: coronavirus disease. Int J Pept Res Ther 27:651\u2013658. https:\/\/doi.org\/10.1007\/s10989-020-10115-6","journal-title":"Int J Pept Res Ther"},{"key":"798_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305934","volume":"19","author":"AR Alanzi","year":"2024","unstructured":"Alanzi AR, Alsalhi MS, Mothana RA et al (2024) Insilico discovery of novel phosphodiesterase 4 (PDE4) inhibitors for the treatment of psoriasis: insights from computer aided drug design approaches. PLoS ONE 19:e0305934. https:\/\/doi.org\/10.1371\/journal.pone.0305934","journal-title":"PLoS ONE"},{"key":"798_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2024\/1114928","volume":"2024","author":"S Vaziri-Amjad","year":"2024","unstructured":"Vaziri-Amjad S, Rahgosha R, Taherkhani A (2024) Potential JAK2 inhibitors from selected natural compounds: a promising approach for complementary therapy in cancer patients. Evid Based Complement Alternat Med 2024:1\u201320. https:\/\/doi.org\/10.1155\/2024\/1114928","journal-title":"Evid Based Complement Alternat Med"},{"key":"798_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010201","volume":"12","author":"P Chunarkar-Patil","year":"2024","unstructured":"Chunarkar-Patil P, Kaleem M, Mishra R et al (2024) Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicines 12:201. https:\/\/doi.org\/10.3390\/biomedicines12010201","journal-title":"Biomedicines"},{"key":"798_CR125","doi-asserted-by":"publisher","DOI":"10.34133\/jbioxresearch.0041","author":"S Roy","year":"2025","unstructured":"Roy S, Nagaraj K, Mittal A et al (2025) Artificial intelligence in virtual screening: transforming drug research and discovery\u2014a review. J Bio-X Res. https:\/\/doi.org\/10.34133\/jbioxresearch.0041","journal-title":"J Bio-X Res"},{"key":"798_CR126","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae081","author":"H Wang","year":"2024","unstructured":"Wang H (2024) Prediction of protein\u2013ligand binding affinity via deep learning models. Brief Bioinf. https:\/\/doi.org\/10.1093\/bib\/bbae081","journal-title":"Brief Bioinf"},{"key":"798_CR127","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1021\/acs.jcim.6b00740","volume":"57","author":"M Ragoza","year":"2017","unstructured":"Ragoza M, Hochuli J, Idrobo E et al (2017) Protein\u2013ligand scoring with convolutional neural networks. J Chem Inf Model 57:942\u2013957. https:\/\/doi.org\/10.1021\/acs.jcim.6b00740","journal-title":"J Chem Inf Model"},{"key":"798_CR128","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.3390\/molecules27144568","volume":"27","author":"C Yang","year":"2022","unstructured":"Yang C, Chen EA, Zhang Y (2022) Protein-ligand docking in the machine-learning era. Molecules 27:4568. https:\/\/doi.org\/10.3390\/molecules27144568","journal-title":"Molecules"},{"key":"798_CR129","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583\u2013589. https:\/\/doi.org\/10.1038\/s41586-021-03819-2","journal-title":"Nature"},{"key":"798_CR130","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1039\/d4dd00343h","volume":"4","author":"B Cree","year":"2025","unstructured":"Cree B, Bieniek MK, Amin S et al (2025) Active learning driven prioritisation of compounds from on-demand libraries targeting the SARS-CoV-2 main protease. Digit Discov 4:438\u2013450. https:\/\/doi.org\/10.1039\/d4dd00343h","journal-title":"Digit Discov"},{"key":"798_CR131","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1016\/j.csbj.2022.09.002","volume":"20","author":"Y Sun","year":"2022","unstructured":"Sun Y, Jiao Y, Shi C, Zhang Y (2022) Deep learning-based molecular dynamics simulation for structure-based drug design against SARS-CoV-2. Comput Struct Biotechnol J 20:5014\u20135027. https:\/\/doi.org\/10.1016\/j.csbj.2022.09.002","journal-title":"Comput Struct Biotechnol J"},{"key":"798_CR132","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/cbdd.13388","volume":"93","author":"MT Muhammed","year":"2019","unstructured":"Muhammed MT, Aki-Yalcin E (2019) Homology modeling in drug discovery: overview, current applications, and future perspectives. Chem Biol Drug Des 93:12\u201320. https:\/\/doi.org\/10.1111\/cbdd.13388","journal-title":"Chem Biol Drug Des"},{"key":"798_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2023.1120370","author":"LMF Bertoline","year":"2023","unstructured":"Bertoline LMF, Lima AN, Krieger JE, Teixeira SK (2023) Before and after AlphaFold2: an overview of protein structure prediction. Front Bioinform. https:\/\/doi.org\/10.3389\/fbinf.2023.1120370","journal-title":"Front Bioinform"},{"key":"798_CR134","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"key":"798_CR135","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.csbj.2020.07.012","volume":"18","author":"S Makigaki","year":"2020","unstructured":"Makigaki S, Ishida T (2020) Sequence alignment generation using intermediate sequence search for homology modeling. Comput Struct Biotechnol J 18:2043\u20132050. https:\/\/doi.org\/10.1016\/j.csbj.2020.07.012","journal-title":"Comput Struct Biotechnol J"},{"key":"798_CR136","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41587-024-02353-6","volume":"43","author":"L Hong","year":"2025","unstructured":"Hong L, Hu Z, Sun S et al (2025) Fast, sensitive detection of protein homologs using deep dense retrieval. Nat Biotechnol 43:983\u2013995. https:\/\/doi.org\/10.1038\/s41587-024-02353-6","journal-title":"Nat Biotechnol"},{"key":"798_CR137","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/biom12040546","volume":"12","author":"J Chao","year":"2022","unstructured":"Chao J, Tang F, Xu L (2022) Developments in algorithms for sequence alignment: a review. Biomolecules 12:546. https:\/\/doi.org\/10.3390\/biom12040546","journal-title":"Biomolecules"},{"key":"798_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031731","volume":"25","author":"S Rosignoli","year":"2024","unstructured":"Rosignoli S, Lustrino E, Di Silverio I, Paiardini A (2024) Making use of averaging methods in MODELLER for protein structure prediction. Int J Mol Sci 25:1731. https:\/\/doi.org\/10.3390\/ijms25031731","journal-title":"Int J Mol Sci"},{"key":"798_CR139","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.csbj.2019.12.007","volume":"18","author":"AE Badaczewska-Dawid","year":"2020","unstructured":"Badaczewska-Dawid AE, Kolinski A, Kmiecik S (2020) Computational reconstruction of atomistic protein structures from coarse-grained models. Comput Struct Biotechnol J 18:162\u2013176. https:\/\/doi.org\/10.1016\/j.csbj.2019.12.007","journal-title":"Comput Struct Biotechnol J"},{"key":"798_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121662","volume":"16","author":"FA Binbay","year":"2023","unstructured":"Binbay FA, Rathod DC, George AAP, Imhof D (2023) Quality assessment of selected protein structures derived from homology modeling and AlphaFold. Pharmaceuticals 16:1662. https:\/\/doi.org\/10.3390\/ph16121662","journal-title":"Pharmaceuticals"},{"key":"798_CR141","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/17460441.2022.2029843","volume":"17","author":"C Mantzourani","year":"2022","unstructured":"Mantzourani C, Vasilakaki S, Gerogianni V-E, Kokotos G (2022) The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. Expert Opin Drug Discov 17:231\u2013246. https:\/\/doi.org\/10.1080\/17460441.2022.2029843","journal-title":"Expert Opin Drug Discov"},{"key":"798_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00639-8","author":"H Zhu","year":"2024","unstructured":"Zhu H, Hixson P, Ma W, Sun J (2024) Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM. Cell Discov. https:\/\/doi.org\/10.1038\/s41421-023-00639-8","journal-title":"Cell Discov"},{"key":"798_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s43141-020-00102-1","volume":"19","author":"M Abdullahi","year":"2021","unstructured":"Abdullahi M, Adeniji SE, Arthur DE, Haruna A (2021) Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis. J Genet Eng Biotechnol 19:12. https:\/\/doi.org\/10.1186\/s43141-020-00102-1","journal-title":"J Genet Eng Biotechnol"},{"key":"798_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2025.102691","volume":"9","author":"S Mozaffari","year":"2025","unstructured":"Mozaffari S, Moen A, Ng CY et al (2025) Structural bioinformatics for rational drug design. Res Pract Thromb Haemost 9:102691. https:\/\/doi.org\/10.1016\/j.rpth.2025.102691","journal-title":"Res Pract Thromb Haemost"},{"key":"798_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2023.107959","volume":"215","author":"PJ Harrison","year":"2023","unstructured":"Harrison PJ, Vecerkova T, Clare DK, Quigley A (2023) A review of the approaches used to solve sub-100 kDa membrane proteins by cryo-electron microscopy. J Struct Biol 215:107959. https:\/\/doi.org\/10.1016\/j.jsb.2023.107959","journal-title":"J Struct Biol"},{"key":"798_CR146","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.gpb.2022.11.014","volume":"21","author":"B Huang","year":"2023","unstructured":"Huang B, Kong L, Wang C et al (2023) Protein structure prediction: challenges, advances, and the shift of research paradigms. Genom Proteom Bioinform 21:913\u2013925. https:\/\/doi.org\/10.1016\/j.gpb.2022.11.014","journal-title":"Genom Proteom Bioinform"},{"key":"798_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30026-y","author":"H Abbasi Mesrabadi","year":"2023","unstructured":"Abbasi Mesrabadi H, Faez K, Pirgazi J (2023) Drug\u2013target interaction prediction based on protein features, using wrapper feature selection. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-30026-y","journal-title":"Sci Rep"},{"key":"798_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2024.102334","volume":"5","author":"Z Pei","year":"2024","unstructured":"Pei Z (2024) Computer-aided drug discovery: from traditional simulation methods to language models and quantum computing. Cell Rep Phys Sci 5:102334. https:\/\/doi.org\/10.1016\/j.xcrp.2024.102334","journal-title":"Cell Rep Phys Sci"},{"key":"798_CR149","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1021\/acs.jcim.3c00643","volume":"63","author":"A Hagg","year":"2023","unstructured":"Hagg A, Kirschner KN (2023) Open-source machine learning in computational chemistry. J Chem Inf Model 63:4505\u20134532. https:\/\/doi.org\/10.1021\/acs.jcim.3c00643","journal-title":"J Chem Inf Model"},{"key":"798_CR150","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/bioinformatics\/btaa010","volume":"36","author":"X Zeng","year":"2020","unstructured":"Zeng X, Zhu S, Hou Y et al (2020) Network-based prediction of drug\u2013target interactions using an arbitrary-order proximity embedded deep forest. Bioinformatics 36:2805\u20132812. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa010","journal-title":"Bioinformatics"},{"key":"798_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-025-00442-z","author":"W Jiang","year":"2025","unstructured":"Jiang W, Ye W, Tan X, Bao Y-J (2025) Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BioData Mining. https:\/\/doi.org\/10.1186\/s13040-025-00442-z","journal-title":"BioData Mining"},{"key":"798_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-023-00720-0","author":"S-Q Yang","year":"2023","unstructured":"Yang S-Q, Zhang L-X, Ge Y-J et al (2023) In-silico target prediction by ensemble chemogenomic model based on multi-scale information of chemical structures and protein sequences. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-023-00720-0","journal-title":"J Cheminform"},{"key":"798_CR153","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/e25111517","volume":"25","author":"J Wang","year":"2023","unstructured":"Wang J, Ning J, Nie L et al (2023) A link prediction algorithm based on weighted local and global closeness. Entropy 25:1517. https:\/\/doi.org\/10.3390\/e25111517","journal-title":"Entropy"},{"key":"798_CR154","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1109\/tcbb.2018.2832078","volume":"16","author":"H Luo","year":"2019","unstructured":"Luo H, Wang J, Li M et al (2019) Computational drug repositioning with random walk on a heterogeneous network. IEEE ACM Trans Comput Biol Bioinform 16:1890\u20131900. https:\/\/doi.org\/10.1109\/tcbb.2018.2832078","journal-title":"IEEE ACM Trans Comput Biol Bioinform"},{"key":"798_CR155","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1016\/j.csbj.2023.10.038","volume":"21","author":"F Ahmed","year":"2023","unstructured":"Ahmed F, Yang YJ, Samantasinghar A et al (2023) Network-based drug repurposing for HPV-associated cervical cancer. Comput Struct Biotechnol J 21:5186\u20135200. https:\/\/doi.org\/10.1016\/j.csbj.2023.10.038","journal-title":"Comput Struct Biotechnol J"},{"key":"798_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110438","volume":"196","author":"A Vefghi","year":"2025","unstructured":"Vefghi A, Rahmati Z, Akbari M (2025) Drug-target interaction\/affinity prediction: deep learning models and advances review. Comput Biol Med 196:110438. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110438","journal-title":"Comput Biol Med"},{"key":"798_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004760","volume":"12","author":"Y Liu","year":"2016","unstructured":"Liu Y, Wu M, Miao C et al (2016) Neighborhood regularized logistic matrix factorization for drug-target interaction prediction. PLoS Comput Biol 12:e1004760. https:\/\/doi.org\/10.1371\/journal.pcbi.1004760","journal-title":"PLoS Comput Biol"},{"key":"798_CR158","doi-asserted-by":"publisher","DOI":"10.1007\/s10462-023-10669-z","author":"M Besharatifard","year":"2024","unstructured":"Besharatifard M, Vafaee F (2024) A review on graph neural networks for predicting synergistic drug combinations. Artif Intell Rev. https:\/\/doi.org\/10.1007\/s10462-023-10669-z","journal-title":"Artif Intell Rev"},{"key":"798_CR159","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae461","author":"P Perdomo-Quinteiro","year":"2024","unstructured":"Perdomo-Quinteiro P, Belmonte-Hern\u00e1ndez A (2024) Knowledge Graphs for drug repurposing: a review of databases and methods. Brief Bioinf. https:\/\/doi.org\/10.1093\/bib\/bbae461","journal-title":"Brief Bioinf"},{"key":"798_CR160","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s42256-025-00987-y","volume":"7","author":"J De La Fuente","year":"2025","unstructured":"De La Fuente J, Serrano G, Veleiro U et al (2025) Towards a more inductive world for drug repurposing approaches. Nat Mach Intell 7:495\u2013508. https:\/\/doi.org\/10.1038\/s42256-025-00987-y","journal-title":"Nat Mach Intell"},{"key":"798_CR161","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/bioinformatics\/btp433","volume":"25","author":"K Bleakley","year":"2009","unstructured":"Bleakley K, Yamanishi Y (2009) Supervised prediction of drug\u2013target interactions using bipartite local models. Bioinformatics 25:2397\u20132403. https:\/\/doi.org\/10.1093\/bioinformatics\/btp433","journal-title":"Bioinformatics"},{"key":"798_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04812-w","author":"H Wang","year":"2022","unstructured":"Wang H, Guo F, Du M et al (2022) A novel method for drug-target interaction prediction based on graph transformers model. BMC Bioinformatics. https:\/\/doi.org\/10.1186\/s12859-022-04812-w","journal-title":"BMC Bioinformatics"},{"key":"798_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101604","volume":"52","author":"T Sha\u2019ban","year":"2025","unstructured":"Sha\u2019ban T, Mustafa AM, Ali MZ (2025) WAE-DTI: ensemble-based architecture for drug\u2013target interaction prediction using descriptors and embeddings. Inform Med Unlocked 52:101604. https:\/\/doi.org\/10.1016\/j.imu.2024.101604","journal-title":"Inform Med Unlocked"},{"key":"798_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-3518-6","author":"H Eslami Manoochehri","year":"2020","unstructured":"Eslami Manoochehri H, Nourani M (2020) Drug-target interaction prediction using semi-bipartite graph model and deep learning. BMC Bioinf. https:\/\/doi.org\/10.1186\/s12859-020-3518-6","journal-title":"BMC Bioinf"},{"key":"798_CR165","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tips.2019.04.001","volume":"40","author":"PA Insel","year":"2019","unstructured":"Insel PA, Sriram K, Gorr MW et al (2019) GPCRomics: an approach to discover GPCR drug targets. Trends Pharmacol Sci 40:378\u2013387. https:\/\/doi.org\/10.1016\/j.tips.2019.04.001","journal-title":"Trends Pharmacol Sci"},{"key":"798_CR166","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab275","author":"Q An","year":"2021","unstructured":"An Q, Yu L (2021) A heterogeneous network embedding framework for predicting similarity-based drug-target interactions. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab275","journal-title":"Brief Bioinform"},{"key":"798_CR167","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.ajpath.2019.03.009","volume":"189","author":"LY-H Lee","year":"2019","unstructured":"Lee LY-H, Loscalzo J (2019) Network medicine in pathobiology. Am J Pathol 189:1311\u20131326. https:\/\/doi.org\/10.1016\/j.ajpath.2019.03.009","journal-title":"Am J Pathol"},{"key":"798_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s13326-025-00328-","author":"Y Pu","year":"2025","unstructured":"Pu Y, Beck D, Verspoor K (2025) Enriched knowledge representation in biological fields: a case study of literature-based discovery in Alzheimer\u2019s disease. J Biomed Semant. https:\/\/doi.org\/10.1186\/s13326-025-00328-","journal-title":"J Biomed Semant"},{"key":"798_CR169","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baab017","author":"E Kropiwnicki","year":"2021","unstructured":"Kropiwnicki E, Evangelista JE, Stein DJ et al (2021) Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning. Database. https:\/\/doi.org\/10.1093\/database\/baab017","journal-title":"Database"},{"key":"798_CR170","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1021\/acs.chemrestox.3c00352","volume":"37","author":"AMB Amorim","year":"2024","unstructured":"Amorim AMB, Piochi LF, Gaspar AT et al (2024) Advancing drug safety in drug development: bridging computational predictions for enhanced toxicity prediction. Chem Res Toxicol 37:827\u2013849. https:\/\/doi.org\/10.1021\/acs.chemrestox.3c00352","journal-title":"Chem Res Toxicol"},{"key":"798_CR171","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1162\/dint_a_00149","volume":"5","author":"L Zhang","year":"2022","unstructured":"Zhang L, Ouyang C, Hu F et al (2022) Relational topology-based heterogeneous network embedding for predicting drug-target interactions. Data Intell 5:475\u2013493. https:\/\/doi.org\/10.1162\/dint_a_00149","journal-title":"Data Intell"},{"key":"798_CR172","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-022-00253-y","author":"G Panditrao","year":"2022","unstructured":"Panditrao G, Bhowmick R, Meena C, Sarkar RR (2022) Emerging landscape of molecular interaction networks: opportunities, challenges and prospects. J Biosci. https:\/\/doi.org\/10.1007\/s12038-022-00253-y","journal-title":"J Biosci"},{"key":"798_CR173","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.aiopen.2021.01.001","volume":"1","author":"J Zhou","year":"2020","unstructured":"Zhou J, Cui G, Hu S et al (2020) Graph neural networks: a review of methods and applications. AI Open 1:57\u201381. https:\/\/doi.org\/10.1016\/j.aiopen.2021.01.001","journal-title":"AI Open"},{"key":"798_CR174","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18224","author":"J Cao","year":"2024","unstructured":"Cao J, Chen Q, Qiu J et al (2024) NGCN: drug-target interaction prediction by integrating information and feature learning from heterogeneous network. J Cellular Molecular Medi. https:\/\/doi.org\/10.1111\/jcmm.18224","journal-title":"J Cellular Molecular Medi"},{"key":"798_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101336","author":"M Wang","year":"2025","unstructured":"Wang M, Lei X, Guo L et al (2025) DHGT-DTI: advancing drug-target interaction prediction through a dual-view heterogeneous network with GraphSAGE and graph transformer. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2025.101336","journal-title":"J Pharm Anal"},{"key":"798_CR176","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1021\/acsomega.0c05377","volume":"6","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Wu Z (2021) A machine learning-based biological drug-target interaction prediction method for a tripartite heterogeneous network. ACS Omega 6:3037\u20133045. https:\/\/doi.org\/10.1021\/acsomega.0c05377","journal-title":"ACS Omega"},{"key":"798_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05376-z","author":"SS Boyd","year":"2023","unstructured":"Boyd SS, Slawson C, Thompson JA (2023) AMEND: active module identification using experimental data and network diffusion. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-023-05376-z","journal-title":"BMC Bioinform"},{"key":"798_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.csite.2025.105946","volume":"69","author":"S Abbas","year":"2025","unstructured":"Abbas S, Ahmad M, Nazar M et al (2025) Artificial neural network analysis of heat and mass transfer in fractional Casson flow. Case Stud Therm Eng 69:105946. https:\/\/doi.org\/10.1016\/j.csite.2025.105946","journal-title":"Case Stud Therm Eng"},{"key":"798_CR179","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1039\/d1sc05613a","volume":"13","author":"Z Wu","year":"2022","unstructured":"Wu Z, Ma H, Liu Z et al (2022) wSDTNBI: a novel network-based inference method for virtual screening. Chem Sci 13:1060\u20131079. https:\/\/doi.org\/10.1039\/d1sc05613a","journal-title":"Chem Sci"},{"key":"798_CR180","doi-asserted-by":"publisher","DOI":"10.14569\/ijacsa.2021.01208100","author":"S Kaur","year":"2021","unstructured":"Kaur S, Gupta A, Saxena R (2021) Identifying central nodes in directed and weighted networks. IJACSA. https:\/\/doi.org\/10.14569\/ijacsa.2021.01208100","journal-title":"IJACSA"},{"key":"798_CR181","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01134","author":"Z Wu","year":"2018","unstructured":"Wu Z, Li W, Liu G, Tang Y (2018) Network-based methods for prediction of drug-target interactions. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.01134","journal-title":"Front Pharmacol"},{"key":"798_CR182","doi-asserted-by":"publisher","DOI":"10.1007\/s11831-025-10260-5","author":"ID Mienye","year":"2025","unstructured":"Mienye ID, Swart TG (2025) Deep autoencoder neural networks: a comprehensive review and new perspectives. Arch Comput Methods Eng. https:\/\/doi.org\/10.1007\/s11831-025-10260-5","journal-title":"Arch Comput Methods Eng"},{"key":"798_CR183","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1039\/c5mb00615e","volume":"12","author":"X-Y Yan","year":"2016","unstructured":"Yan X-Y, Zhang S-W, Zhang S-Y (2016) Prediction of drug\u2013target interaction by label propagation with mutual interaction information derived from heterogeneous network. Mol BioSyst 12:520\u2013531. https:\/\/doi.org\/10.1039\/c5mb00615e","journal-title":"Mol BioSyst"},{"key":"798_CR184","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ipha.2024.11.003","volume":"3","author":"S Javid","year":"2025","unstructured":"Javid S, Rahmanulla A, Ahmed MG et al (2025) Machine learning & deep learning tools in pharmaceutical sciences: a comprehensive review. Intell Pharm 3:167\u2013180. https:\/\/doi.org\/10.1016\/j.ipha.2024.11.003","journal-title":"Intell Pharm"},{"key":"798_CR185","doi-asserted-by":"publisher","first-page":"i232","DOI":"10.1093\/bioinformatics\/btn162","volume":"24","author":"Y Yamanishi","year":"2008","unstructured":"Yamanishi Y, Araki M, Gutteridge A et al (2008) Prediction of drug\u2013target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24:i232\u2013i240. https:\/\/doi.org\/10.1093\/bioinformatics\/btn162","journal-title":"Bioinformatics"},{"key":"798_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00680-8","author":"Y Luo","year":"2017","unstructured":"Luo Y, Zhao X, Zhou J et al (2017) A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-017-00680-8","journal-title":"Nat Commun"},{"key":"798_CR187","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1007\/s10462-022-10306-1","volume":"56","author":"H Askr","year":"2023","unstructured":"Askr H, Elgeldawi E, Aboul Ella H et al (2023) Deep learning in drug discovery: an integrative review and future challenges. Artif Intell Rev 56:5975\u20136037. https:\/\/doi.org\/10.1007\/s10462-022-10306-1","journal-title":"Artif Intell Rev"},{"key":"798_CR188","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s11030-021-10225-3","volume":"25","author":"JM Vaz","year":"2021","unstructured":"Vaz JM, Balaji S (2021) Convolutional neural networks (CNNs): concepts and applications in pharmacogenomics. Mol Divers 25:1569\u20131584. https:\/\/doi.org\/10.1007\/s11030-021-10225-3","journal-title":"Mol Divers"},{"key":"798_CR189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007129","volume":"15","author":"I Lee","year":"2019","unstructured":"Lee I, Keum J, Nam H (2019) DeepConv-DTI: prediction of drug-target interactions via deep learning with convolution on protein sequences. PLoS Comput Biol 15:e1007129. https:\/\/doi.org\/10.1371\/journal.pcbi.1007129","journal-title":"PLoS Comput Biol"},{"key":"798_CR190","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1553743","author":"G Deng","year":"2025","unstructured":"Deng G, Shi C, Ge R et al (2025) Efficient substructure feature encoding based on graph neural network blocks for drug-target interaction prediction. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1553743","journal-title":"Front Pharmacol"},{"key":"798_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-05976-3","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang Y, Wu C et al (2024) Drug\u2013target interaction prediction by integrating heterogeneous information with mutual attention network. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-024-05976-3","journal-title":"BMC Bioinform"},{"key":"798_CR192","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/bioinformatics\/btaa880","volume":"37","author":"K Huang","year":"2021","unstructured":"Huang K, Xiao C, Glass LM, Sun J (2021) MolTrans: molecular interaction transformer for drug\u2013target interaction prediction. Bioinformatics 37:830\u2013836. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa880","journal-title":"Bioinformatics"},{"key":"798_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06425-2","author":"M Lin","year":"2025","unstructured":"Lin M, Guo J, Gu Z et al (2025) Machine learning and multi-omics integration: advancing cardiovascular translational research and clinical practice. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-025-06425-2","journal-title":"J Transl Med"},{"key":"798_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45566-8","volume":"15","author":"D Buterez","year":"2024","unstructured":"Buterez D, Janet JP, Kiddle SJ et al (2024) Transfer learning with graph neural networks for improved molecular property prediction in the multi-fidelity setting. Nat Commun 15:1517. https:\/\/doi.org\/10.1038\/s41467-024-45566-8","journal-title":"Nat Commun"},{"key":"798_CR195","unstructured":"Sun Y, Lu Y, Li YY, et al (2025) MolGraph-xLSTM: A graph-based dual-level xLSTM framework with multi-head mixture-of-experts for enhanced molecular representation and interpretability"},{"key":"798_CR196","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-024-00915-z","volume":"16","author":"C Zonyfar","year":"2024","unstructured":"Zonyfar C, Ngnamsie Njimbouom S, Mosalla S, Kim J-D (2024) GTransCYPs: an improved graph transformer neural network with attention pooling for reliably predicting CYP450 inhibitors. J Cheminform 16:119. https:\/\/doi.org\/10.1186\/s13321-024-00915-z","journal-title":"J Cheminform"},{"key":"798_CR197","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-025-01068-3","volume":"17","author":"T Lee","year":"2025","unstructured":"Lee T, Posma JM (2025) Improving drug-induced liver injury prediction using graph neural networks with augmented graph features from molecular optimisation. J Cheminform 17:124. https:\/\/doi.org\/10.1186\/s13321-025-01068-3","journal-title":"J Cheminform"},{"key":"798_CR198","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1186\/s12864-024-11022-6","volume":"25","author":"H Xia","year":"2024","unstructured":"Xia H, Dong C, Chen X et al (2024) SGTCDA: Prediction of circRNA-drug sensitivity associations with interpretable graph transformers and effective assessment. BMC Genom 25:1113. https:\/\/doi.org\/10.1186\/s12864-024-11022-6","journal-title":"BMC Genom"},{"key":"798_CR199","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1039\/D5DD00170F","volume":"4","author":"R Sheshanarayana","year":"2025","unstructured":"Sheshanarayana R, You F (2025) Molecular representation learning: cross-domain foundations and future frontiers. Digit Discov 4:2298\u20132335. https:\/\/doi.org\/10.1039\/D5DD00170F","journal-title":"Digit Discov"},{"key":"798_CR200","doi-asserted-by":"crossref","unstructured":"Li X, Gui J, Gao Q, et al (2024) Controllable edge-type-specific interpretation in multi-relational graph neural networks for drug response prediction","DOI":"10.1007\/978-981-95-0030-7_43"},{"key":"798_CR201","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-025-02456-9","volume":"23","author":"A Xiong","year":"2025","unstructured":"Xiong A, Luo Z, Xia Y et al (2025) An interpretable geometric graph neural network for enhancing the generalizability of drug\u2013target interaction prediction. BMC Biol 23:350. https:\/\/doi.org\/10.1186\/s12915-025-02456-9","journal-title":"BMC Biol"},{"key":"798_CR202","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae162","author":"P Jia","year":"2024","unstructured":"Jia P, Zhang F, Wu C, Li M (2024) A comprehensive review of protein-centric predictors for biomolecular interactions: from proteins to nucleic acids and beyond. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbae162","journal-title":"Brief Bioinform"},{"key":"798_CR203","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-025-02302-y","author":"S Jin","year":"2025","unstructured":"Jin S, Long H, Huang A et al (2025) Accurate prediction of synergistic drug combination using a multi-source information fusion framework. BMC Biol. https:\/\/doi.org\/10.1186\/s12915-025-02302-y","journal-title":"BMC Biol"},{"key":"798_CR204","unstructured":"Nie Y, Song Y, Peng H (2025) ADGSyn: dual-stream learning for efficient anticancer drug synergy prediction"},{"key":"798_CR205","doi-asserted-by":"crossref","unstructured":"Ge X, Lee Y-T, Yeh S-J (2025) MD-Syn: synergistic drug combination prediction based on the multidimensional feature fusion method and attention mechanisms","DOI":"10.3389\/fphar.2025.1564339"},{"key":"798_CR206","unstructured":"He Z, Liu L, Han D, et al (2025) POINT: a web-based platform for pharmacological investigation enhanced by multi-omics networks and knowledge graphs"},{"key":"798_CR207","doi-asserted-by":"publisher","first-page":"12279","DOI":"10.1021\/acs.jcim.5c02063","volume":"65","author":"R Gorantla","year":"2025","unstructured":"Gorantla R, Gema AP, Yang IX et al (2025) Learning binding affinities via fine-tuning of protein and ligand language models. J Chem Inf Model 65:12279\u201312291. https:\/\/doi.org\/10.1021\/acs.jcim.5c02063","journal-title":"J Chem Inf Model"},{"key":"798_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2024.125264","volume":"259","author":"Y Xie","year":"2025","unstructured":"Xie Y, Wang X, Wang P, Bi X (2025) A pseudo-label supervised graph fusion attention network for drug\u2013target interaction prediction. Expert Syst Appl 259:125264. https:\/\/doi.org\/10.1016\/j.eswa.2024.125264","journal-title":"Expert Syst Appl"},{"key":"798_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01464-x","volume":"8","author":"H He","year":"2025","unstructured":"He H, Chen G, Tang Z, Chen CY-C (2025) Dual modality feature fused neural network integrating binding site information for drug target affinity prediction. npj Digit Med 8:67. https:\/\/doi.org\/10.1038\/s41746-025-01464-x","journal-title":"npj Digit Med"},{"key":"798_CR210","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-024-00897-y","author":"Y Ohnuki","year":"2024","unstructured":"Ohnuki Y, Akiyama M, Sakakibara Y (2024) Deep learning of multimodal networks with topological regularization for drug repositioning. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-024-00897-y","journal-title":"J Cheminform"},{"key":"798_CR211","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae238","author":"W Zhao","year":"2024","unstructured":"Zhao W, Yu Y, Liu G et al (2024) MSI-DTI: predicting drug-target interaction based on multi-source information and multi-head self-attention. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbae238","journal-title":"Brief Bioinform"},{"key":"798_CR212","doi-asserted-by":"crossref","unstructured":"Meng Z, Meng Z, Yuan K, Ounis I (2024) FusionDTI: fine-grained binding discovery with token-level fusion for drug-target interaction","DOI":"10.18653\/v1\/2025.findings-emnlp.237"},{"key":"798_CR213","doi-asserted-by":"publisher","DOI":"10.1002\/aisy.202300546","volume":"6","author":"G Chen","year":"2024","unstructured":"Chen G, He H, Chen CY-C (2024) MFAE: multilevel feature aggregation enhanced drug\u2010target affinity prediction for drug repurposing against colorectal cancer. Adv Intell Syst 6:2300546. https:\/\/doi.org\/10.1002\/aisy.202300546","journal-title":"Adv Intell Syst"},{"key":"798_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2023.108003","volume":"244","author":"C Zhou","year":"2024","unstructured":"Zhou C, Li Z, Song J, Xiang W (2024) TransVAE-DTA: transformer and variational autoencoder network for drug-target binding affinity prediction. Comput Methods Programs Biomed 244:108003. https:\/\/doi.org\/10.1016\/j.cmpb.2023.108003","journal-title":"Comput Methods Programs Biomed"},{"key":"798_CR215","doi-asserted-by":"publisher","DOI":"10.1007\/s11432-022-3793-7","volume":"67","author":"H He","year":"2024","unstructured":"He H, Chen G, Chen CY-C (2024) Integrating sequence and graph information for enhanced drug-target affinity prediction. Sci China Inf Sci 67:129101. https:\/\/doi.org\/10.1007\/s11432-022-3793-7","journal-title":"Sci China Inf Sci"},{"key":"798_CR216","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03876-3","author":"Z-H Ren","year":"2023","unstructured":"Ren Z-H, You Z-H, Zou Q et al (2023) DeepMPF: deep learning framework for predicting drug\u2013target interactions based on multi-modal representation with meta-path semantic analysis. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-023-03876-3","journal-title":"J Transl Med"},{"key":"798_CR217","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-05925-0","author":"S Monem","year":"2024","unstructured":"Monem S, Hassanien AE, Abdel-Hamid AH (2024) A multi-task graph deep learning model to predict drugs combination of synergy and sensitivity scores. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-024-05925-0","journal-title":"BMC Bioinform"},{"key":"798_CR218","doi-asserted-by":"crossref","unstructured":"Bai P, Miljkovi\u0107 F, John B, Lu H (2023) Interpretable bilinear attention network with domain adaptation improves drug-target prediction","DOI":"10.1038\/s42256-022-00605-1"},{"key":"798_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-04245-4","author":"A Raies","year":"2022","unstructured":"Raies A, Tulodziecka E, Stainer J et al (2022) DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-022-04245-4","journal-title":"Commun Biol"},{"key":"798_CR220","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008653","volume":"17","author":"Q Liu","year":"2021","unstructured":"Liu Q, Xie L (2021) TranSynergy: mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations. PLoS Comput Biol 17:e1008653. https:\/\/doi.org\/10.1371\/journal.pcbi.1008653","journal-title":"PLoS Comput Biol"},{"key":"798_CR221","doi-asserted-by":"publisher","first-page":"W527","DOI":"10.1093\/nar\/gkac376","volume":"50","author":"G Zhou","year":"2022","unstructured":"Zhou G, Pang Z, Lu Y et al (2022) OmicsNet 2.0: a web-based platform for multi-omics integration and network visual analytics. Nucleic Acids Res 50:W527\u2013W533. https:\/\/doi.org\/10.1093\/nar\/gkac376","journal-title":"Nucleic Acids Res"},{"key":"798_CR222","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1039\/C8SC00148K","volume":"9","author":"A Mayr","year":"2018","unstructured":"Mayr A, Klambauer G, Unterthiner T et al (2018) Large-scale comparison of machine learning methods for drug target prediction on ChEMBL. Chem Sci 9:5441\u20135451. https:\/\/doi.org\/10.1039\/C8SC00148K","journal-title":"Chem Sci"},{"key":"798_CR223","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13982","author":"S Yang","year":"2023","unstructured":"Yang S, Zhu G, He R et al (2023) Advances in transcriptomics and proteomics in differentiated thyroid cancer: an updated perspective (Review). Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2023.13982","journal-title":"Oncol Lett"},{"key":"798_CR224","doi-asserted-by":"publisher","DOI":"10.3390\/biom14060692","volume":"14","author":"P Du","year":"2024","unstructured":"Du P, Fan R, Zhang N et al (2024) Advances in integrated multi-omics analysis for drug-target identification. Biomolecules 14:692. https:\/\/doi.org\/10.3390\/biom14060692","journal-title":"Biomolecules"},{"key":"798_CR225","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1039\/c9sc04336e","volume":"11","author":"X Zeng","year":"2020","unstructured":"Zeng X, Zhu S, Lu W et al (2020) Target identification among known drugs by deep learning from heterogeneous networks. Chem Sci 11:1775\u20131797. https:\/\/doi.org\/10.1039\/c9sc04336e","journal-title":"Chem Sci"},{"key":"798_CR226","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-024-00391-z","author":"JL Ballard","year":"2024","unstructured":"Ballard JL, Wang Z, Li W et al (2024) Deep learning-based approaches for multi-omics data integration and analysis. BioData Min. https:\/\/doi.org\/10.1186\/s13040-024-00391-z","journal-title":"BioData Min"},{"key":"798_CR227","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030332","volume":"16","author":"L Marques","year":"2024","unstructured":"Marques L, Costa B, Pereira M et al (2024) Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics 16:332. https:\/\/doi.org\/10.3390\/pharmaceutics16030332","journal-title":"Pharmaceutics"},{"key":"798_CR228","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fphar.2018.00923","volume":"9","author":"V Salmaso","year":"2018","unstructured":"Salmaso V, Moro S (2018) Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview. Front Pharmacol 9:923. https:\/\/doi.org\/10.3389\/fphar.2018.00923","journal-title":"Front Pharmacol"},{"key":"798_CR229","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac229","volume":"23","author":"TJ Rintala","year":"2022","unstructured":"Rintala TJ, Ghosh A, Fortino V (2022) Network approaches for modeling the effect of drugs and diseases. Br Bioinform 23:bbac229. https:\/\/doi.org\/10.1093\/bib\/bbac229","journal-title":"Br Bioinform"},{"key":"798_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.array.2025.100393","volume":"26","author":"AK Kausik","year":"2025","unstructured":"Kausik AK, Rashid AB, Baki RF, Maktum JMM (2025) Machine learning algorithms for manufacturing quality assurance: a systematic review of performance metrics and applications. Array 26:100393. https:\/\/doi.org\/10.1016\/j.array.2025.100393","journal-title":"Array"},{"key":"798_CR231","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-021-00444-8","volume":"8","author":"L Alzubaidi","year":"2021","unstructured":"Alzubaidi L, Zhang J, Humaidi AJ et al (2021) Review of deep learning: concepts, CNN architectures, challenges, applications, future directions. J Big Data 8:53. https:\/\/doi.org\/10.1186\/s40537-021-00444-8","journal-title":"J Big Data"},{"key":"798_CR232","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s44345-025-00037-5","volume":"2","author":"A Pathak","year":"2025","unstructured":"Pathak A, Theagarajan R, Rizqi MM et al (2025) AI-enabled drug and molecular discovery: computational methods, platforms, and translational horizons. Discov Mol 2:32. https:\/\/doi.org\/10.1007\/s44345-025-00037-5","journal-title":"Discov Mol"},{"key":"798_CR233","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.315","volume":"4","author":"C Chen","year":"2023","unstructured":"Chen C, Wang J, Pan D et al (2023) Applications of multi\u2010omics analysis in human diseases. MedComm 4:e315. https:\/\/doi.org\/10.1002\/mco2.315","journal-title":"MedComm"},{"key":"798_CR234","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/bib\/bbz157","volume":"22","author":"M Bagherian","year":"2021","unstructured":"Bagherian M, Sabeti E, Wang K et al (2021) Machine learning approaches and databases for prediction of drug\u2013target interaction: a survey paper. Br Bioinform 22:247\u2013269. https:\/\/doi.org\/10.1093\/bib\/bbz157","journal-title":"Br Bioinform"},{"key":"798_CR235","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bay083","author":"Z Tanoli","year":"2018","unstructured":"Tanoli Z, Alam Z, V\u00e4h\u00e4-Koskela M et al (2018) Drug target commons 2.0: a community platform for systematic analysis of drug\u2013target interaction profiles. Database. https:\/\/doi.org\/10.1093\/database\/bay083","journal-title":"Database"},{"key":"798_CR236","unstructured":"PubChem BioAssays. https:\/\/pubchem.ncbi.nlm.nih.gov\/docs\/bioassays. Accessed 12 July 2025"},{"key":"798_CR237","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Zhao D et al (2024) TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res 52:D1465\u2013D1477. https:\/\/doi.org\/10.1093\/nar\/gkad751","journal-title":"Nucleic Acids Res"},{"key":"798_CR238","unstructured":"KEGG PATHWAY Database. https:\/\/www.genome.jp\/kegg\/pathway.html. Accessed 12 July 2025"},{"key":"798_CR239","unstructured":"PharmGKB. In: PharmGKB. https:\/\/www.pharmgkb.org\/. Accessed 12 July 2025"},{"key":"798_CR240","doi-asserted-by":"crossref","unstructured":"Hu P-W, Chan KCC, You Z-H (2016) Large-scale prediction of drug-target interactions from deep representations. In: 2016 International joint conference on neural networks (IJCNN). IEEE, Vancouver, BC, pp 1236\u20131243","DOI":"10.1109\/IJCNN.2016.7727339"},{"key":"798_CR241","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-022-03165-8","author":"S Nag","year":"2022","unstructured":"Nag S, Baidya ATK, Mandal A et al (2022) Deep learning tools for advancing drug discovery and development. 3 Biotech. https:\/\/doi.org\/10.1007\/s13205-022-03165-8","journal-title":"3 Biotech"},{"key":"798_CR242","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae496","volume":"40","author":"A Schulman","year":"2024","unstructured":"Schulman A, Rousu J, Aittokallio T, Tanoli Z (2024) Attention-based approach to predict drug\u2013target interactions across seven target superfamilies. Bioinformatics 40:btae496. https:\/\/doi.org\/10.1093\/bioinformatics\/btae496","journal-title":"Bioinformatics"},{"key":"798_CR243","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae328","volume":"25","author":"A Ianevski","year":"2024","unstructured":"Ianevski A, Kushnir A, Nader K et al (2024) RepurposeDrugs: an interactive web-portal and predictive platform for repurposing mono- and combination therapies. Br Bioinform 25:bbae328. https:\/\/doi.org\/10.1093\/bib\/bbae328","journal-title":"Br Bioinform"},{"key":"798_CR244","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24980-2","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Aldahdooh J, Hu Y et al (2022) DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features. Sci Rep 12:21116. https:\/\/doi.org\/10.1038\/s41598-022-24980-2","journal-title":"Sci Rep"},{"key":"798_CR245","doi-asserted-by":"publisher","first-page":"W57","DOI":"10.1093\/nar\/gkad390","volume":"51","author":"S Potdar","year":"2023","unstructured":"Potdar S, Ianevski F, Ianevski A et al (2023) Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data. Nucleic Acids Res 51:W57\u2013W61. https:\/\/doi.org\/10.1093\/nar\/gkad390","journal-title":"Nucleic Acids Res"},{"key":"798_CR246","doi-asserted-by":"publisher","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk H, \u00d6zg\u00fcr A, Ozkirimli E (2018) DeepDTA: deep drug\u2013target binding affinity prediction. Bioinformatics 34:i821\u2013i829. https:\/\/doi.org\/10.1093\/bioinformatics\/bty593","journal-title":"Bioinformatics"},{"key":"798_CR247","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","volume":"37","author":"T Nguyen","year":"2021","unstructured":"Nguyen T, Le H, Quinn TP et al (2021) GraphDTA: predicting drug\u2013target binding affinity with graph neural networks. Bioinformatics 37:1140\u20131147. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa921","journal-title":"Bioinformatics"},{"key":"798_CR248","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/bioinformatics\/bty543","volume":"35","author":"F Wan","year":"2019","unstructured":"Wan F, Hong L, Xiao A et al (2019) NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug\u2013target interactions. Bioinformatics 35:104\u2013111. https:\/\/doi.org\/10.1093\/bioinformatics\/bty543","journal-title":"Bioinformatics"},{"issue":"22\u201323","key":"798_CR249","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.48550\/ARXIV.2004.08919","volume":"36","author":"K Huang","year":"2020","unstructured":"Huang K, Fu T, Glass L et al (2020) DeepPurpose: a deep learning library for drug-target interaction prediction. Bioinformatics 36(22\u201323):5545\u20135547. https:\/\/doi.org\/10.48550\/ARXIV.2004.08919","journal-title":"Bioinformatics"},{"key":"798_CR250","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acs.jcim.3c01250","volume":"64","author":"E Heid","year":"2024","unstructured":"Heid E, Greenman KP, Chung Y et al (2024) Chemprop: a machine learning package for chemical property prediction. J Chem Inf Model 64:9\u201317. https:\/\/doi.org\/10.1021\/acs.jcim.3c01250","journal-title":"J Chem Inf Model"},{"key":"798_CR251","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkq367","volume":"38","author":"M Hattori","year":"2010","unstructured":"Hattori M, Tanaka N, Kanehisa M, Goto S (2010) SIMCOMP\/SUBCOMP: chemical structure search servers for network analyses. Nucleic Acids Res 38:W652\u2013W656. https:\/\/doi.org\/10.1093\/nar\/gkq367","journal-title":"Nucleic Acids Res"},{"key":"798_CR252","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/bioinformatics\/btx139","volume":"33","author":"D Schlauch","year":"2017","unstructured":"Schlauch D, Paulson JN, Young A et al (2017) Estimating gene regulatory networks with pandaR. Bioinformatics 33:2232\u20132234. https:\/\/doi.org\/10.1093\/bioinformatics\/btx139","journal-title":"Bioinformatics"},{"key":"798_CR253","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c04017","volume":"6","author":"M Li","year":"2021","unstructured":"Li M, Zhou J, Hu J et al (2021) DGL-LifeSci: an open-source toolkit for deep learning on graphs in life science. ACS Omega 6:27233\u201327238. https:\/\/doi.org\/10.1021\/acsomega.1c04017","journal-title":"ACS Omega"},{"key":"798_CR254","doi-asserted-by":"publisher","first-page":"W514","DOI":"10.1093\/nar\/gky510","volume":"46","author":"G Zhou","year":"2018","unstructured":"Zhou G, Xia J (2018) OmicsNet: a web-based tool for creation and visual analysis of biological networks in 3D space. Nucleic Acids Res 46:W514\u2013W522. https:\/\/doi.org\/10.1093\/nar\/gky510","journal-title":"Nucleic Acids Res"},{"key":"798_CR255","doi-asserted-by":"publisher","first-page":"D1633","DOI":"10.1093\/nar\/gkae1075","volume":"53","author":"T Liu","year":"2025","unstructured":"Liu T, Hwang L, Burley SK et al (2025) BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data. Nucleic Acids Res 53:D1633\u2013D1644. https:\/\/doi.org\/10.1093\/nar\/gkae1075","journal-title":"Nucleic Acids Res"},{"key":"798_CR256","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-023-00762-4","author":"V Chandrasekhar","year":"2023","unstructured":"Chandrasekhar V, Sharma N, Schaub J et al (2023) Cheminformatics microservice: unifying access to open cheminformatics toolkits. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-023-00762-4","journal-title":"J Cheminform"},{"key":"798_CR257","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaf081","author":"J Reinshagen","year":"2025","unstructured":"Reinshagen J, Seashore-Ludlow B, Gadiya Y et al (2025) From library to landscape: integrative annotation workflows for compound libraries in drug repurposing. Database. https:\/\/doi.org\/10.1093\/database\/baaf081","journal-title":"Database"},{"key":"798_CR258","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17460441.2021.1883585","volume":"16","author":"Z Tanoli","year":"2021","unstructured":"Tanoli Z, V\u00e4h\u00e4-Koskela M, Aittokallio T (2021) Artificial intelligence, machine learning, and drug repurposing in cancer. Expert Opin Drug Discov 16:977\u2013989. https:\/\/doi.org\/10.1080\/17460441.2021.1883585","journal-title":"Expert Opin Drug Discov"},{"key":"798_CR259","doi-asserted-by":"publisher","first-page":"14061","DOI":"10.3390\/ijms241814061","volume":"24","author":"Y Huang","year":"2023","unstructured":"Huang Y, Huang H-Y, Chen Y et al (2023) A robust drug-target interaction prediction framework with capsule network and transfer learning. IJMS 24:14061. https:\/\/doi.org\/10.3390\/ijms241814061","journal-title":"IJMS"},{"key":"798_CR260","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16493-9","author":"K Dick","year":"2022","unstructured":"Dick K, Kyrollos DG, Cosoreanu ED et al (2022) Reciprocal perspective as a super learner improves drug-target interaction prediction (MUSDTI). Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-16493-9","journal-title":"Sci Rep"},{"key":"798_CR261","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/1751-7915.13937","volume":"15","author":"A Danchin","year":"2022","unstructured":"Danchin A (2022) In vivo, in vitro and in silico: an open space for the development of microbe-based applications of synthetic biology. Microb Biotechnol 15:42\u201364. https:\/\/doi.org\/10.1111\/1751-7915.13937","journal-title":"Microb Biotechnol"},{"key":"798_CR262","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6906722","author":"CNS De Sousa","year":"2022","unstructured":"De Sousa CNS, Da Silva Medeiros I, Vasconcelos GS et al (2022) Anxiolytic effect of carvedilol in chronic unpredictable stress model. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/6906722","journal-title":"Oxid Med Cell Longev"},{"key":"798_CR263","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04230-7","author":"F Wang","year":"2022","unstructured":"Wang F, Chen Y-T, Yang J-M, Akutsu T (2022) A novel graph convolutional neural network for predicting interaction sites on protein kinase inhibitors in phosphorylation. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-04230-7","journal-title":"Sci Rep"},{"key":"798_CR264","first-page":"559","volume":"2023","author":"M Pillai","year":"2023","unstructured":"Pillai M, Wu D (2023) Validation approaches for computational drug repurposing: a review. AMIA Annu Symp Proc 2023:559\u2013568","journal-title":"AMIA Annu Symp Proc"},{"key":"798_CR265","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58606-8","volume":"16","author":"R Joeres","year":"2025","unstructured":"Joeres R, Blumenthal DB, Kalinina OV (2025) Data splitting to avoid information leakage with DataSAIL. Nat Commun 16:3337. https:\/\/doi.org\/10.1038\/s41467-025-58606-8","journal-title":"Nat Commun"},{"key":"798_CR266","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-025-01039-8","volume":"17","author":"Q Guo","year":"2025","unstructured":"Guo Q, Hernandez-Hernandez S, Ballester PJ (2025) UMAP-based clustering split for rigorous evaluation of AI models for virtual screening on cancer cell lines*. J Cheminform 17:94. https:\/\/doi.org\/10.1186\/s13321-025-01039-8","journal-title":"J Cheminform"},{"key":"798_CR267","doi-asserted-by":"publisher","first-page":"bbac269","DOI":"10.1093\/bib\/bbac269","volume":"23","author":"TM Nguyen","year":"2022","unstructured":"Nguyen TM, Nguyen T, Tran T (2022) Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring. Brief Bioinf 23:bbac269. https:\/\/doi.org\/10.1093\/bib\/bbac269","journal-title":"Brief Bioinf"},{"key":"798_CR268","doi-asserted-by":"publisher","first-page":"bba454","DOI":"10.1093\/bib\/bbaf454","volume":"26","author":"J Lee","year":"2025","unstructured":"Lee J, Hao Nguyen C, Mamitsuka H (2025) Beyond rigid docking: deep learning approaches for fully flexible protein\u2013ligand interactions. Brief Bioinf 26:bba454. https:\/\/doi.org\/10.1093\/bib\/bbaf454","journal-title":"Brief Bioinf"},{"key":"798_CR269","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/17460441.2024.2430955","volume":"20","author":"Z Tanoli","year":"2025","unstructured":"Tanoli Z, Schulman A, Aittokallio T (2025) Validation guidelines for drug-target prediction methods. Expert Opin Drug Discov 20:31\u201345. https:\/\/doi.org\/10.1080\/17460441.2024.2430955","journal-title":"Expert Opin Drug Discov"},{"key":"798_CR270","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes11040034","volume":"11","author":"T Ivanisevic","year":"2023","unstructured":"Ivanisevic T, Sewduth RN (2023) Multi-omics integration for the design of novel therapies and the identification of novel biomarkers. Proteomes 11:34. https:\/\/doi.org\/10.3390\/proteomes11040034","journal-title":"Proteomes"},{"key":"798_CR271","doi-asserted-by":"publisher","first-page":"49","DOI":"10.32604\/or.2023.042383","volume":"32","author":"Q Chen","year":"2024","unstructured":"Chen Q, Guo X, Ma W (2024) Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy. Oncol Res 32:49\u201360. https:\/\/doi.org\/10.32604\/or.2023.042383","journal-title":"Oncol Res"},{"key":"798_CR272","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.105049","volume":"141","author":"MU Anwaar","year":"2022","unstructured":"Anwaar MU, Adnan F, Abro A et al (2022) Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. Comput Biol Med 141:105049. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.105049","journal-title":"Comput Biol Med"},{"key":"798_CR273","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1080\/17460441.2024.2387856","volume":"19","author":"A Parise","year":"2024","unstructured":"Parise A, Cresca S, Magistrato A (2024) Molecular dynamics simulations for the structure-based drug design: targeting small-GTPases proteins. Expert Opin Drug Discov 19:1259\u20131279. https:\/\/doi.org\/10.1080\/17460441.2024.2387856","journal-title":"Expert Opin Drug Discov"},{"key":"798_CR274","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05572-x","author":"R Amiri","year":"2023","unstructured":"Amiri R, Razmara J, Parvizpour S, Izadkhah H (2023) A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-023-05572-x","journal-title":"BMC Bioinform"},{"key":"798_CR275","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02321-x","author":"Y Mao","year":"2025","unstructured":"Mao Y, Shangguan D, Huang Q et al (2025) Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-025-02321-x","journal-title":"Mol Cancer"},{"key":"798_CR276","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101275","volume":"15","author":"Y Yan","year":"2025","unstructured":"Yan Y, Yang Y, Tong Z et al (2025) Adaptive multi-view learning method for enhanced drug repurposing using chemical-induced transcriptional profiles, knowledge graphs, and large language models. J Pharm Anal 15:101275. https:\/\/doi.org\/10.1016\/j.jpha.2025.101275","journal-title":"J Pharm Anal"},{"key":"798_CR277","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03932-6","author":"MdA Talukder","year":"2025","unstructured":"Talukder MdA, Kazi M, Alazab A (2025) Predicting drug-target interactions using machine learning with improved data balancing and feature engineering. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-025-03932-6","journal-title":"Sci Rep"},{"key":"798_CR278","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-024-00808-1","author":"J Lee","year":"2024","unstructured":"Lee J, Jun DW, Song I, Kim Y (2024) DLM-DTI: a dual language model for the prediction of drug-target interaction with hint-based learning. J Cheminform. https:\/\/doi.org\/10.1186\/s13321-024-00808-1","journal-title":"J Cheminform"},{"key":"798_CR279","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1109\/tcbb.2022.3190266","volume":"20","author":"TM Nguyen","year":"2023","unstructured":"Nguyen TM, Quinn TP, Nguyen T, Tran T (2023) Explaining black box drug target prediction through model agnostic counterfactual samples. IEEE ACM Trans Comput Biol Bioinform 20:1020\u20131029. https:\/\/doi.org\/10.1109\/tcbb.2022.3190266","journal-title":"IEEE ACM Trans Comput Biol Bioinform"},{"key":"798_CR280","unstructured":"Hartog PBR Current limitations of text-based molecular representations for machine learning in small molecule drug discovery"},{"key":"798_CR281","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/1365-2656.70054","volume":"94","author":"O Wilson","year":"2025","unstructured":"Wilson O, Schoeman D, Bradley A, Clemente C (2025) Practical guidelines for validation of supervised machine learning models in accelerometer-based animal behaviour classification. J Anim Ecol 94:1322\u20131334. https:\/\/doi.org\/10.1111\/1365-2656.70054","journal-title":"J Anim Ecol"},{"key":"798_CR282","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00509","author":"P Sidorov","year":"2019","unstructured":"Sidorov P, Naulaerts S, Ariey-Bonnet J et al (2019) Predicting synergism of cancer drug combinations using NCI-ALMANAC data. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2019.00509","journal-title":"Front Chem"},{"key":"798_CR283","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1109\/tcbb.2021.3103966","volume":"19","author":"Y Pu","year":"2022","unstructured":"Pu Y, Li J, Tang J, Guo F (2022) DeepFusionDTA: drug-target binding affinity prediction with information fusion and hybrid deep-learning ensemble model. IEEE ACM Trans Comput Biol Bioinform 19:2760\u20132769. https:\/\/doi.org\/10.1109\/tcbb.2021.3103966","journal-title":"IEEE ACM Trans Comput Biol Bioinform"},{"key":"798_CR284","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/bib\/bbaa003","volume":"22","author":"Z Tanoli","year":"2021","unstructured":"Tanoli Z, Seemab U, Scherer A et al (2021) Exploration of databases and methods supporting drug repurposing: a comprehensive survey. Brief Bioinform 22:1656\u20131678. https:\/\/doi.org\/10.1093\/bib\/bbaa003","journal-title":"Brief Bioinform"},{"key":"798_CR285","unstructured":"Sahpo A, Mondal S, Okunola A, Charandarl N Demystifying black box models: the importance of explainable AI"},{"key":"798_CR286","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab271","author":"K Fan","year":"2021","unstructured":"Fan K, Cheng L, Li L (2021) Artificial intelligence and machine learning methods in predicting anti-cancer drug combination effects. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab271","journal-title":"Brief Bioinform"},{"key":"798_CR287","doi-asserted-by":"publisher","DOI":"10.1016\/j.medntd.2025.100375","volume":"27","author":"P Kandhare","year":"2025","unstructured":"Kandhare P, Kurlekar M, Deshpande T, Pawar A (2025) Artificial intelligence in pharmaceutical sciences: a comprehensive review. Med Novel Technol Devices 27:100375. https:\/\/doi.org\/10.1016\/j.medntd.2025.100375","journal-title":"Med Novel Technol Devices"},{"key":"798_CR288","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2024.101551","volume":"50","author":"EM Mohammed","year":"2024","unstructured":"Mohammed EM, Fakhrudeen AM, Alani OY (2024) Detection of Alzheimer\u2019s disease using deep learning models: a systematic literature review. Inform Med Unlocked 50:101551. https:\/\/doi.org\/10.1016\/j.imu.2024.101551","journal-title":"Inform Med Unlocked"},{"key":"798_CR289","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2021.10.022","volume":"27","author":"A Bess","year":"2022","unstructured":"Bess A, Berglind F, Mukhopadhyay S et al (2022) Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases. Drug Discov Today 27:1099\u20131107. https:\/\/doi.org\/10.1016\/j.drudis.2021.10.022","journal-title":"Drug Discov Today"},{"key":"798_CR290","unstructured":"Gracias A Federated learning: collaborative model training without data sharing"},{"key":"798_CR291","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2024.108400","volume":"257","author":"P Yang","year":"2024","unstructured":"Yang P, Chen W, Qiu H (2024) MMGCN: multi-modal multi-view graph convolutional networks for cancer prognosis prediction. Comput Methods Programs Biomed 257:108400. https:\/\/doi.org\/10.1016\/j.cmpb.2024.108400","journal-title":"Comput Methods Programs Biomed"},{"key":"798_CR292","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-024-00503-y","author":"HO Uzoeto","year":"2024","unstructured":"Uzoeto HO, Cosmas S, Bakare TT, Durojaye OA (2024) AlphaFold-latest: revolutionizing protein structure prediction for comprehensive biomolecular insights and therapeutic advancements. Beni-Suef Univ J Basic Appl Sci. https:\/\/doi.org\/10.1186\/s43088-024-00503-y","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"5","key":"798_CR293","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/0115734064318640241112071225","volume":"21","author":"IH Eissa","year":"2025","unstructured":"Eissa IH, Elkaeed EB, Elwan A et al (2025) Identification of potential FDA-approved inhibitors of SARS-CoV-2 helicase through a multistep in silico approach: a promising prospect for COVID-19 treatment. Med Chem 21(5):425\u2013441. https:\/\/doi.org\/10.2174\/0115734064318640241112071225","journal-title":"Med Chem"},{"key":"798_CR294","doi-asserted-by":"publisher","DOI":"10.62311\/nesx\/rphcrcscrqc5","author":"MK Pasupuleti","year":"2025","unstructured":"Pasupuleti MK (2025) Hybrid quantum-classical algorithms for drug discovery and molecular simulation. IJAIRI. https:\/\/doi.org\/10.62311\/nesx\/rphcrcscrqc5","journal-title":"IJAIRI"},{"key":"798_CR295","doi-asserted-by":"publisher","DOI":"10.3389\/fcomp.2025.1464122","author":"G Pallavi","year":"2025","unstructured":"Pallavi G, Prasanna Kumar R (2025) Quantum natural language processing and its applications in bioinformatics: a comprehensive review of methodologies, concepts, and future directions. Front Comput Sci. https:\/\/doi.org\/10.3389\/fcomp.2025.1464122","journal-title":"Front Comput Sci"},{"key":"798_CR296","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-024-01356-2","author":"A Marey","year":"2024","unstructured":"Marey A, Arjmand P, Alerab ADS et al (2024) Explainability, transparency and black box challenges of AI in radiology: impact on patient care in cardiovascular radiology. Egypt J Radiol Nucl Med. https:\/\/doi.org\/10.1186\/s43055-024-01356-2","journal-title":"Egypt J Radiol Nucl Med"},{"key":"798_CR297","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-05847-x","volume":"25","author":"S Sadeghi","year":"2024","unstructured":"Sadeghi S, Bui A, Forooghi A et al (2024) Can large language models understand molecules? BMC Bioinform 25:225. https:\/\/doi.org\/10.1186\/s12859-024-05847-x","journal-title":"BMC Bioinform"},{"key":"798_CR298","doi-asserted-by":"publisher","first-page":"vbae106","DOI":"10.1093\/bioadv\/vbae106","volume":"4","author":"J Aldahdooh","year":"2024","unstructured":"Aldahdooh J, Tanoli Z, Tang J (2024) Mining drug\u2013target interactions from biomedical literature using chemical and gene descriptions-based ensemble transformer model. Bioinform Adv 4:vbae106. https:\/\/doi.org\/10.1093\/bioadv\/vbae106","journal-title":"Bioinform Adv"},{"key":"798_CR299","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04768-x","volume":"23","author":"J Aldahdooh","year":"2022","unstructured":"Aldahdooh J, V\u00e4h\u00e4-Koskela M, Tang J, Tanoli Z (2022) Using BERT to identify drug-target interactions from whole PubMed. BMC Bioinformatics 23:245. https:\/\/doi.org\/10.1186\/s12859-022-04768-x","journal-title":"BMC Bioinformatics"},{"key":"798_CR300","doi-asserted-by":"publisher","DOI":"10.3390\/ph18010047","volume":"18","author":"F Mirakhori","year":"2025","unstructured":"Mirakhori F, Niazi SK (2025) Harnessing the AI\/ML in drug and biological products discovery and development: the regulatory perspective. Pharmaceuticals Basel 18:47. https:\/\/doi.org\/10.3390\/ph18010047","journal-title":"Pharmaceuticals Basel"},{"key":"798_CR301","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.241873","author":"T Pham","year":"2025","unstructured":"Pham T (2025) Ethical and legal considerations in healthcare AI: innovation and policy for safe and fair use. R Soc Open Sci. https:\/\/doi.org\/10.1098\/rsos.241873","journal-title":"R Soc Open Sci"},{"key":"798_CR302","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.2174\/1568026622666220701091339","volume":"22","author":"P Pasrija","year":"2022","unstructured":"Pasrija P, Jha P, Upadhyaya P et al (2022) Machine learning and artificial intelligence: a paradigm shift in big data-driven drug design and discovery. CTMC 22:1692\u20131727. https:\/\/doi.org\/10.2174\/1568026622666220701091339","journal-title":"CTMC"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00798-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00798-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00798-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:23:18Z","timestamp":1774855398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00798-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":302,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00798-2","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"89"}}